home  catalent sign up now to stay current with the latest news and insights subscribe now development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us catalent is the  partner in helping pharmaceutical biotech and consumer health innovators develop deliver and supply superior products that improve people’s lives play video how can we work together drug development delivery  supply biologics consumer health explore the range of delivery options for your molecule this web tool enables drug development professionals to solve one of the most challenging aspects in drug development determining the optimal finished dose suited to your specific product requirements target indication and molecule properties learn more how can we work together drug development delivery  supply biologics consumer health why catalent unrivaled experience expertise and a track recordof market successes on a global scalelearn more about us how can we work together drug development delivery  supply biologics consumer health latest news pfizer partners with catalent on the new advil® liquigels® minis launch catalent launches expanded optiform® solution suite a complete early development offering catalent pharma solutions has launched the expanded optiform® solution suite platform extending the scope of the service to efficiently guide a molecule’s progress from candidate selection to phase i clinic supplies using integrated capabilities and a datadriven process for faster early phase development  learn more our solutions improve your treatments at every stage catalent shares the passion to unlock the potential of your product offering comprehensive solutions and superior technologies for oral biologic sterile and inhaled dose forms at every phase  from preclinical formulation through commercial supply clinical supply services need to accelerate your clinical trial partner with a leading global provider of integrated clinical trial supply solutions from clinical manufacturing packaging and comparator procurement to global logistics we can help optiform® pro web tool what dose form would work the best for your challenging molecule our tool can provide multiple sciencebased options try it now our facilities around the world enable us to tailor a solution to fit your needs see all of our locationsor visit our local language siteschinajapansouth america spanishportuguese news events twitter catalent applied drug delivery institute appoints jim spavins to advisory board jul   catalent applied drug delivery institute partners with rutgers university jul   catalent launches new optiform® solution suite jul   aug  expofybi  buenos aires argentina sep  vitafoods asia singapore asia sep  controlled  modified drug release philadelphia pa view all view all follow us catalentpharma resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement careers  catalent development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us catalent careers join the global drug development and delivery leader and help develop some of the nearly  products we launch each year or help supply over  products for patients around the world overviewjob openings values  culture our employees are focused on continuous improvement innovation and quality training  development expand your skills with our specialized training and development programs benefits learn more about our comprehensive benefits program selection process here’s what you can expect from the catalent selection process executive careers join one of the most dynamic leadership teams in the pharmaceutical industry gold program accelerate career growth in an entrepreneurial fastpaced corporate environment students  graduates regardless of your degree catalent is a great place to begin your career veterans we are seeking veterans for open positions at catalent notice to recruitment agencies resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement contact us development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us home contact us  share print contact us connect with the right expert now catalent offers solutions across your drug development delivery and supply globally  so we need your help to match you with the right experts in the right place tell us your challenge and well get back to you within  hours phone  additional contact options the more we know the faster we can find the best expert for yourequired field name  companyorganisation  phone email  region  please select north america latin america emea china japan australia asia excl chinajapan other what is the purpose of your contact  please select considering solutions for an immediate need evaluating solutions for a project within  months researching solutions for a project greater than  months away no need for a solution just researching the topic provide as much as detail as possible about your challenge  select one primary area of interest  development analytical services cell line development inhalation  respiratory services smartag technology particle size reduction optiform® solution suite optiform® solution suite bio spray dried dispersion delivery softgel rx softgel consumer health hot melt extrusion blow  fill  seal controlled release cosmetics  skin care undecided drug delivery oral fast dissolve zydis supply biologics biomanufacturing clinical supply services comparator sourcing sterile fill  finish regulatory consulting error please see areas highlighted in red submit to see a full list of open positions at catalent and to apply today please click here  to reach the accounts payable department directly please call  to reach the accounts receivable department directly please call   select one primary area of interest  please select analytical services cell line development inhalation  respiratory services smartag technology particle size reduction optiform® solution suite optiform® solution suite bio spray dried dispersion softgel rx softgel consumer health hot melt extrusion blow  fill  seal controlled release cosmetics  skin care undecided drug delivery oral fast dissolve zydis biologics biomanufacturing clinical supply services comparator sourcing sterile fill  finish regulatory consulting error please see areas highlighted in red submit to see a full list of open positions at catalent and to apply today please click here  to reach the accounts payable department directly please call  to reach the accounts receivable department directly please call   connect with the right expert now catalent offers solutions across your drug development delivery and supply globally  so we need your help to match you with the right experts in the right place tell us your challenge and well get back to you within  hours call us us  eurow     corporate services catalent pharma solutions   schoolhouse road somerset nj see all our locations  for general inquiriesclick here  for information on  catalent careersclick here  resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement about us  catalent development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us about us catalyst  talent our name combines these ideas as the worlds  drug development delivery and supply partner for drugs biologics and consumer health products we are the catalyst for your successmore about us catalent under the lens see catalent by the numbers and what makes us a global leader our locations find out about our worldwide facilities our leadership meet our worldclass executive and scientific talent resource center download our brochures offering information and more in our thinking section our leadership meet our worldclass executive and scientific talent resource center download our brochures offering information and more in our thinking section get involved catalent applied drug delivery institute developming better treatments for patients by advancing drug delivery technologies innovation at catalent we are seeking new technologies and partners that can help bring solutions to market careers explore how we recruit and train top talent to catalyze our success high business standards as a leading development delivery and supply partner we conduct all our business responsibly and with integrity our customers investors and suppliers count on it and our company’s continued success depends on it standards of business conduct corporate social responsibility quality  compliance personal data privacy development with our broad range of expert services we drive faster more efficient development timelines and produce better products preformulation formulation biologics analytical services small molecule analytical chemistry delivery we are a world leader in drug delivery solutions with a proven track record of helping our customers create better treatments controlled release delivery inhalation overview injectable delivery rp scherer softgel technology zydis® fast dissolve supply as a seamless extension of your supply chain we offer global integrated manufacturing and packaging solutions clinical supply management global comparator sourcing manufacturing  blinding blowfillseal controlled release manufacturing view all development offerings view all delivery offerings view all supply offerings resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement our locations development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us home about us our locations  share print our locations with our broad range of experience and deep expertise we have the talent and unique technologies to transform your concepts into excellent results this is backed by our global reach with facilities located worldwide enabling us to tailor a solution to fit your needs browse by capability all biologics clinical supply services development  analytical modified release softgel sterile technologies biologics clinical supply services development  analytical modified release softgel sterile technologies view all asia pacific   braeside melbourne au  dee why sydney au  ftz shanghai china  haining china  kakegawa japan  shanghai china  singapore  tokyo japan  europe   aprilia rome italy  bathgate scotland  beinheim france  bolton uk  brussels belgium  cham switzerland  dartford uk  eberbach germany  limoges france  schorndorf germany  swindon uk  latin america   buenos aires argentina  indaiatuba brazil  montevideo uruguay  sorocaba brazil  north america   emeryville ca  kansas city mo  madison wi  malvern pa  morrisvillertp nc  philadelphia pa  san diego ca  somerset nj hq  st petersburg fl  strathroy ontario canada  winchester ky  windsor ontario canada  woodstock il  resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement catalentunder the lens we have proudly built  locations around the globe with a total of over m square feet or enough space to house  boeing s see the bigger picture here offerings  catalent development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us overview video offerings with the broadest range of services and technologies to transform your molecule into a successful treatment—from specific challenges tailored solutions or fullyintegrated supportbrowse all offerings broadest offerings deepest expertise whatever your challenge we can help from development to delivery to supply we can improve the total value of your treatmentsplay video  featured offerings development solutions and services as the  global industry partner in drug development we can help you bring more molecules to market faster bioavailability solutions solve solubility and permeability challenges deliver more apis and optimize delivery profiles with our deep expertise and innovative technologies drug delivery technologies from orphan drugs to blockbusters our development expertise delivery technologies and reliable supply deliver better outcomes for payers patients and innovators accelerated development get your drug to market faster with our deep development expertise integrated solutions and flexible scale view offerings by phase whether you are looking for a single tailored solution or multiple answers throughout your products lifecycle we can improve the total value of your treatments  from discovery to market and beyond learn more browse offerings a to z not sure which are right for you try our solutions finder tool browse by tag browse by tag   view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer looking for case studies downloadable brochures and other resources  visit our resource center advasept® lock easily opened and locks to luered syringes for a smooth withdraw advasept® technology advanced aseptic processing providing a glass free solution for parenterals advasept® vial glass free vials as a proven container closure for biologic products animal health our technologies offer dose forms suitable for a variety of species assessment of abusedeterrence specific testing capabilities in the area of abusedeterrent formulations bioavailability solutions our talent and expertise can solve the most complex bioavailability challenges biologics analytical services leading expertise in protein characterization and bioassays biologics overview we can help build you a smooth path from cell line development to product delivery biomanufacturing increase yield and shorten timeline with our expert biomanufacturing capabilities biosimilars optimized and flexible biosimilar programs blowfillseal customized specialty fillfinish solutions that drive the most efficient patient outcomes catalent micron technologies proven and versatile particle size reduction micronization and milling technologies clinical storage and distribution seamless supply chain management cold chain distribution global shipping and tracking clinical supply management expert support throughout the complete clinical supply project clinical supply services integrated pharma resources and project management for your clinical supply chain coated softgels for pharmaceutical drug products improve therapeutic performance and enhance patients experience compendial testing fullservice compendial release testing in stateoftheart facilities consumer health enhance your brand image with consumers preferred delivery systems controlled release complete range of capabilities for tablets  capsules – from development to supply cosmetics and skin care energy beauty and wellbeing all in a capsule cosmopod™ capsules for beauty  plantbased twist off softgel technology for beauty care dry powder inhalants comprehensive services from dosage form and formulation to clinical trial and packaging early stage oral development accelerate development process with reduced risk  improved outcomes easyburst™ chewable capsules convenient to use and can offer higher efficacy than other confectionary forms enhanced therapeutic profiles explore how we can help optimize the therapeutic profiles of your treatments enteric coated softgels for consumer health products improve product performance  enhance consumer experience esolutions webbased fully collaborative platforms for keeping clients informed and updated extractables and leachables identify and quantify levels of extractable and leachable substances in a drug dosage form flexdose℠ ideal packaging solution for a wide range of powder granule liquid and gel formulations flexible manufacturing proven expertise in technology transfers and product launches global comparator sourcing inhouse sourcing specialists plus a global network for access to virtually any product gpex® technology our unique reliable gene retrovector that generates stable mammalian lines in record time hardshell capsules expert development and manufacturing solutions with a competitive edge highly potent active pharmaceutical ingredients integrated development manufacturing and clinical supply solutions inhalant solutionssuspensions expert support from dosage form selection to clinical and commercialscale manufacturing inhalation overview broadest range of services for aseptic processing across all dosage forms integrated supply chain solutions our one central supply chain frees capital ensures highest quality and speeds time to market manufacturing and blinding fullservice vertical integrated operations for clinical trials – phase  to phase iv manufacturing overview over  years of customizing innovative manufacturing and packaging solutions metals testing high quality laboratory based inspection services method development  validation expertly meeting the specificity demands of analytical assays microbiology testing a complete line of services that includes gmpglpanalytical microbiology services nasal sprays comprehensive development support as well as clinical and commercialscale manufacturing offerings by phase browse our integrated services for your products entire lifecycle optiform® api api screening that provides the most stable crystalline form for  compounds optiform® pro web tool enables professionals to determine the optimal finished dose for your product optiform® select formulation screening fast solubility for preclinical efficacy testing and lead selection optiform® solution suite designed to accelerate more molecules to clinic and beyond optiform® solution suite bio fast macromolecule screening for oral delivery optigel™ bio technology enabling iv to oral conversion of macromolecules optigel™ lock technology enabling abuse deterrence in rp scherer softgel optigel™ micro technology a smaller easy to swallow softgel with the added benefit of dose titration optigel™ mini technology innovative oral softgel platform that delivers full strength apis in a small powerful softgel optimelt® hot melt extrusion optimelt® hot melt extrusion can enhance bioavailability of your poorly soluble api optipact™ technology fast and scalable process for your orphan and accelerated drug development success optishell® technology expanding the range of fill formulations into softgels packaging and labeling advanced technologies and custom solutions to advance your timelines and enhance branding pharmatek™ sd spray drying technology enhance bioavailability of your poorly soluble api prefilled syringes the latest in fillfinish process advanced needle safety and specialty autodevices regulatory consulting proven comprehensive services from regulatory training to global submissions guidance savorgel™ technology easy to administer offers higher compliance and is enjoyable for animals softdrop™ oral technology innovative oral delivery platform capable of delivering multiple actives softgel technology as innovators of softgel technology we offer integrated services across the entire lifecyle stability testing standardcustom preclinical and clinical testing services – placebos to controlled drugs sterile fillfinish expertise from process design to regulatory support for virtually any sterile dosage form structure characterization our expertise encompasses the full range of large and small molecules tablets customized oral solids development and manufacturing to your most stringent requirements vegicaps® capsules our proprietary plantderived shell for semisolid compounds by the softgel innovators zydis® fastdissolve technology our unique solid oral dosage that dissolves instantly in mouth enhancing absorption resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement development  catalent development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us overview video resources development get more products to market faster with the worlds  partner for drug development and formulation servicesour development solutions  services more products our advanced development solutions can help you accelerate your timelines and get more products to market fasterplay video brochure case studies offering info all resources featured development offerings early stage oral development from api optimization to formulation accelerate your path to clinic with the broadest toolkit of technologies and deepest expertise optiform® pro find the best oral drug delivery technology options for your challenging molecule with our patentpending interactive tool accelerated development get your drug to market faster with our deep development expertise integrated solutions and flexible scale optiform® solution suite solve complex bioavailability challenges for early stage molecules using a unique toolkit of bioavailability enhancing technologies early stage oral development accelerate development process with reduced risk  improved outcomes pharmatek™ sd spray drying technology enhance bioavailability of your poorly soluble api solid state services optiform® api screening identifies the most stable crystalline form for  compounds preformulation studies that elucidate the best drug substance for optimal physicochemical properties formulation enhancing projects with cutting edge expertise  from oral to inhalation to sterile bioavailability solutions our talent and expertise can solve the most complex bioavailability challenges small molecule analytical chemistry full analytical services to support rapid product development for small molecules optiform® solution suite designed to accelerate more molecules to clinic and beyond optiform® solution suite bio fast macromolecule screening for oral delivery browse other categories delivery we are a world leader in drug delivery solutions with a proven track record of helping our customers create better treatments controlled release delivery inhalation overview injectable delivery rp scherer softgel technology zydis® fast dissolve supply as a seamless extension of your supply chain we offer global integrated manufacturing and packaging solutions clinical supply management global comparator sourcing manufacturing  blinding blowfillseal controlled release manufacturing about us we offer fullservice capabilities across the entire lifecycle of your product our leadership innovation at catalent our history resource center partner with us view all delivery offerings view all supply offerings view all about us resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement about catalent  catalent development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us home about us about catalent  share print about catalent catalyst  talentour name combines these ideas as the world’s  drug development delivery and supply partner with over  years of experience we are the catalyst for your success we have helped thousands of innovators by optimizing and manufacturing thousands of pharmaceutical biologic consumer health and beauty products utilizing our superior and innovative drug delivery technologies to improve their value to patients and consumerscatalent is a vibrant growing community of  global employees with the passion to unlock the potential of your product founded in  as catalent our legacy of drug development goes much deeper incorporating the inventions and innovations which have transformed the pharmaceutical industry  on july   catalent announced its initial public offering and became a publicly traded on the new york stock exchange under the ticker symbol ctlt for more information on how to join the catalent team click herefrom early development to clinical supply and commercial manufacturing our  global site teams support you through all phases of development delivery and supply accelerating your product’s path to market in segments such as pharmaceuticals biologics consumer health and beauty and animal health utilizing our superior drug delivery technologies to improve therapeutic and product value to patients and consumers whether you seek a single tailored solution or partnership through your product’s entire life cycle we put our experience expertise and passion to work for you in unlocking the potential of your product watch this short video to learn more catalent by numbers additionally we have over  products in development at any time and partner with  of the top  pharmaceutical companies  of the top  biotechnology companies  of the top  generic drug companies  of the top  consumer health companies  catalent more products better treatments reliably supplied™develop more productswe help develop more products with extensive early phase development expertise in analytics biologics preformulation and formulation we help you achieve faster more efficient development timelines to produce better products  in pharmaceuticals we provide expert guidance prescreen solubility assessments for drugability a bestin class api optimization platform and a wide array of the most uptodate bioavailability enhancement tools including particle size reduction spray drying hot melt extrusion and lipid based drug delivery systems in biologics we help accelerate you to clinic and beyond with gpex® technology to generate stable highperformance cell lines  in consumer health we help you deliver innovative products backed by an extensive product library to help get you on the market faster deliver better treatmentswe help deliver better treatments our innovative dose forms and advanced manufacturing technologies help you to create better products and therapeutic outcomes to improve the lives of patients and consumers our superior enabling formulation technologies help you meet your target product profile improve value and achieve better outcomes including rp scherer softgel delivery technologies zydis® fast dissolve delivery technology advasept® glassfree injectable technology smartag® antibody drug conjugate technology and more reliably supplywe help reliably supply your product whether it’s managing your clinical supply needs or commercially manufacturing your products we have a solution for you our clinical supply services will help you manage your local regional or global studies including special handling capabilities and comparator sourcing services our flexible manufacturing solutions will help you scale up and get to market with tailored solutions and special handling capabilities all backed by discipline rigor and rhythm that has resulted in a reliable global network that will supply your product to the highest quality standards on time improve the value of your treatmentwork with us to improve the value of your treatments at every phase discover a solution for every phase of your program browse our integrated services by dosage form we have a solutionevery molecule has a challenge we have a solution use our optiform pro tool to find the best oral drug delivery technologies for your molecule we’ll help you overcome bioavailability challenges and give you guidance quickly and efficiently on your molecule’s optimal formulation pathway with optiform® solution suite for information on exciting opportunities to join our team visit our career center visit our resource center for latest publications from our expertsdiscover more about our executive leadership teaminvestors click here for more information contact us contact us resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement catalentunder the lens with over b oral sterile and inhaled doses produced in  the result is enough for  doses for every human on the planet and over b of them delivered in softgel systems with about  products currently in market catalent will help launch more than  products this year which equals to  new product almost every other day our roster of over  analytical scientists have a combined total of over  years of catalent analytical experience which is enough time for over  trips to the moon and back we are proud to have over  patents and patent applications which total more than  years of exclusive catalent patents or the length of  average us lifetimes we have been involved in over  of new molecular entities approved by the fda launched in the us since  which means if youve taken a product since then there’s more than a  chance catalent worked on it see the bigger picture here investor center  catalent login development delivery supply offerings thinking news amp events about us contact us careers locations investors fusion developmentdeliverysupplyofferingsthinkingnews amp eventsabout uscontact us investors catalent inc is the leading global provider of advanced delivery technologies and development solutions for drugs biologics and consumer health products with over  years serving the industry catalent has proven expertise in bringing more customer products to market faster enhancing product performance and ensuring reliable clinical and commercial product supply catalent employs more than  people including over  scientists at  facilities across five continents and in fiscal  generated more than  billion in annual revenue home investors  share print nyse ctlt price change todays open previous close percent change new york stock exchange recent news catalent inc announces fourth quarter and fiscal year  earnings conference webcast catalent inc to present at william blair  company’s th annual growth stock conference catalent inc to present at the jefferies  healthcare conference more news releases investor related events corporate governance sec filings xbrl documents quick links investor center home company news financial news sec filings annual reports corporate governance stock chart events calendar about us investor faqs presentations ceo interview user links registration login media requests email alerts rss feeds information request search investor center search this site advanced search investor contact investor relations dept catalent inc  schoolhouse roadsomerset nj phone    fax    investorscatalentcom development with our broad range of expert services we drive faster more efficient development timelines and produce better products preformulation formulation biopharmaceutical lab services small molecule analytical chemistry delivery we are a world leader in drug delivery solutions with a proven track record of helping our customers create better treatments controlled release inhalation overview injectable delivery rp scherer softgel technology zydis® fast dissolve supply as a seamless extension of your supply chain we offer global integrated manufacturing and packaging solutions clinical supply management global comparator sourcing manufacturing  blinding blowfillseal controlled release view all development offerings view all delivery offerings view all supply offerings investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms business wire investorhq℠ catalent  wikipedia catalent from wikipedia the free encyclopedia   redirected from catalent pharma solutions jump to navigation search this article contains content that is written like an advertisement please help improve it by removing promotional content and inappropriate external links and by adding encyclopedic content written from a neutral point of view july  learn how and when to remove this template message catalent inc type public company traded as nyse ctlt sp  component industry pharmaceutical biotechnology predecessor cardinal health pts founded  headquarters somerset new jersey usa number of locations  key people john chiminski president ceo matthew walsh executive vice president cfo services drug preformulation formulation analytical testing clinical and commercial manufacturing clinical packaging and supply chain solutions regulatory consulting revenue us billion  operating income us  million  net income us  million  number of employees   website wwwcatalentcom catalent inc catalent pharma solutions is a global provider of drug delivery technology and development solutions for drugs biologics and consumer health products headquartered in somerset new jersey catalent operates  locations across five continents producing more than  billion doses annually for nearly  customer products originally created through a series of acquisitions by cardinal health inc catalent became independent in  catalent promotes its ability to increase customers speed to market and its participation in nearly half of new drug entities approved by the food and drug administration in the last decade the company currently holds approximately  patents and patent applications and continues to expand its offerings through investments in emerging technologies in its fiscal year  ending june  catalent’s customers included  of the top  branded drug marketers  of the top  generics marketers  of the top  biologics marketers and  of the top  consumer health marketers globallycitation needed on july   catalent became a public company and is listed on the new york stock exchange nyse ctlt contents  history  before   formation of catalent in   after  and initial public offering  corporate governance  senior management  drug delivery technologies  centers of excellence  references historyedit before edit in  cardinal health acquired pci headquarters philadelphia pennsylvania pci packaging coordinators inc is a pharmaceutical contract packing service for commercial and clinical packaging in  cardinal health acquired rp scherer corporation headquarters troy michigan robert pauli scherer founded the rp scherer corporation to commercialize his innovation of softgel encapsulation using the rotary die production process in  cardinal health acquired automatic liquid packaging inc headquarters woodstock ill whose blowfillseal technology allowed cardinal to enter the sterile product market cardinal health also acquired international processing corporation headquarters winchester kentucky for its advanced controlled drug release and coating manufacturing expertise in  cardinal health acquired magellan laboratories inc a company that specialized in product development expertise in  cardinal health acquired gala biotech headquarters middleton wisconsin gala biotech had established technologies surrounding gene insertion and the production of pharmaceutical proteins which became gpex® technology in the same year cardinal health also acquired intercare group plc broadening its global capabilities in europe in  cardinal health further expanded its reach in biotechnology and pharmaceutical markets through multiple other acquisitions formation of catalent in edit in  the pharmaceutical technologies and services segment of cardinal health was purchased by blackstone group and rebranded as catalent pharma solutions after  and initial public offeringedit in  the company acquired the molecular optimization platform optiform® from glaxosmithkline in  catalent acquired aptuit a clinical supply solutions company as part of the deal catalent gained three sites in the united states two sites in the united kingdom and one in singapore catalent also acquired all remaining shares for the rp scherer site in eberbach germany in  catalent pharmaceutical solutions continued the global expansion of its softgel capabilities through a joint venture with zhejiang jaing yuan tang biotechnology co a chinabased company and relthy laboratories in brazil also in  catalent created a new business unit advanced delivery technologies which focuses on innovative and proven drug delivery technologies optimizing the company’s multiple technologies crossplatform rd solutions and global commercial manufacturing network this is the current structure of catalent’s business which includes softgel technologies advanced delivery technologies and development  clinical services business units catalent announced its initial public offering on july   after raising more than  million catalent became a publicly traded company on the new york stock exchange nyse the company priced its  million shares of common stock at  apiece with a market capitalization of  billion the shares began trading on the nyse on july   under the ticker symbol ctlt and the offering closed on august   the proceeds of the offering went to the redemption of more than  million of catalent’s outstanding debt “this will allow the company to significantly reduce its interest expense enable future potential internal and external growth strategies and to continue our growthbiased investments into new technologies capabilities global development and manufacturing facilities and capacity” a company statement reported in september  the company acquired the contract drug development and clinical manufacturing company which specializes in early stage development and spray drying pharmatek laboratories in november  the company agreed to acquire canadian based accucaps industries both the strathroy on and windsor on locations will become the th and th softgel technology facilities under the catalent name corporate governanceedit senior managementedit position name since president  chief executive officer and director john r chiminski march  executive vice president and chief financial officer matthew walsh december  president development and clinical services wetteny joseph august  president softgel technologies aris gennadios september  president advanced delivery technologies barry littlejohns july  senior vice president chief information officer michael del priore december  senior vice president global sales  marketing william downie june  senior vice president quality product development and regulatory affairs sharon johnson august  senior vice president global operations stephen leonard june  senior vice president human resources lance miyamoto march  senior vice president general counsel steven fasman october  drug delivery technologiesedit catalents brand currently owns and operates the following drug delivery technologies predevelopment technologies optiform technology catalent micron technologies oral drug delivery technologies rp scherer softgel technology optigel technology optigel lock technology optigel micro technology optigel mini technology zydis technology osdrc optidose drug delivery technology optimelt technology optipact technology sterile technologies advasept technology biologics smartag technology gpex technology centers of excellenceedit catalent has designated the following locations as a center of excellence with the following specializations swindon united kingdom – zydis technology somerset new jersey – osdrc optidose drug delivery technology philadelphia pennsylvania – clinical supply services st petersburg florida – rp scherer softgel technology woodstock illinois – blowfillseal bfs technology winchester kentucky – advanced oral delivery technologies madison wisconsin – gpex technology research triangle park north carolina – inhalation referencesedit  a b c d e f g h i j k l m n the united states securities and exchange commission  form k washington dc catalent pharma solutions catalent pharma solutions retrieved    a b c catalent pharma solutions  catalent reports fourth quarter and fiscal year  results catalent pharma solutions retrieved    our locations catalentcom catalent inc retrieved  nov    a b c d e f cardinal healths timeline  cardinalhealthcom cardinalhealthcom retrieved  april    pci leads the market in healthcare packaging solutions pci services retrieved  april    a b catalent completes acquisition of r p scherer eberbach manufacturing chemist  march  retrieved  april    a b kuehn steven  october  container innovations prairie home pharmaceutical manufacturing retrieved  april    rp scherer to gain new drugdelivery business with acquisition of international processing corporation cmo cro pr newswire  december  retrieved  april    cardinal health to enhance drug development services with acquisition of gala biotech cardinal health inc pr newswire  oct  retrieved  april    cardinal health completes sale of pharmaceutical technologies and services segment to the blackstone group dublin ohio blackstone group  april    ohnesorge lauren k  january  catalent cements local footprint triangle business journal retrieved  april    catalent completes aptuit deal biopharmareportercom  february  retrieved  april    stanton dan  october  catalents brazilian acquisition supports global softgel strategy inpharmatechnologistcom retrieved  april    catalent creates new advanced delivery technologies business unit catalent inc pr web  july  retrieved  april    a b catalent issues initial public offering  pharmtechcom pharmaceutical technology sourcing and management  august  retrieved  april    catalent issues initial public offering catalentcom catalent inc retrieved  april    httpwwwgenengnewscomgennewshighlightscatalenttoacquirepharmatek  httpwwwcatalentcomindexphpnewseventsnewscatalentacquiresaccucapstoexpandsoftgeldevelopmentandmanufacturingcapabilitiesandcapacity  our leadership catalent catalent inc retrieved  nov    a b c catalent announces new optimized drug delivery technologies at cphl worldwideicse redorbit  october  retrieved  april    new optipact™ technology introduced by catalent catalent inc pr web  september  retrieved  april    a b catalent expands its technology offerings in biologics acquires redwood bioscience inc and the smartag™ technology platform catalent pharma solutions marketwatch  october  retrieved  april   retrieved from httpsenwikipediaorgwindexphptitlecatalentoldid categories companies based in somerset county new jerseypharmaceutical companies established in companies listed on the new york stock exchangepharmaceutical companies based in new jerseyhidden categories articles with a promotional tone from july all articles with a promotional toneuse dmy dates from april all articles with unsourced statementsarticles with unsourced statements from july  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  february  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view catalent  wikipedia catalent from wikipedia the free encyclopedia   redirected from catalent pharma solutions jump to navigation search this article contains content that is written like an advertisement please help improve it by removing promotional content and inappropriate external links and by adding encyclopedic content written from a neutral point of view july  learn how and when to remove this template message catalent inc type public company traded as nyse ctlt sp  component industry pharmaceutical biotechnology predecessor cardinal health pts founded  headquarters somerset new jersey usa number of locations  key people john chiminski president ceo matthew walsh executive vice president cfo services drug preformulation formulation analytical testing clinical and commercial manufacturing clinical packaging and supply chain solutions regulatory consulting revenue us billion  operating income us  million  net income us  million  number of employees   website wwwcatalentcom catalent inc catalent pharma solutions is a global provider of drug delivery technology and development solutions for drugs biologics and consumer health products headquartered in somerset new jersey catalent operates  locations across five continents producing more than  billion doses annually for nearly  customer products originally created through a series of acquisitions by cardinal health inc catalent became independent in  catalent promotes its ability to increase customers speed to market and its participation in nearly half of new drug entities approved by the food and drug administration in the last decade the company currently holds approximately  patents and patent applications and continues to expand its offerings through investments in emerging technologies in its fiscal year  ending june  catalent’s customers included  of the top  branded drug marketers  of the top  generics marketers  of the top  biologics marketers and  of the top  consumer health marketers globallycitation needed on july   catalent became a public company and is listed on the new york stock exchange nyse ctlt contents  history  before   formation of catalent in   after  and initial public offering  corporate governance  senior management  drug delivery technologies  centers of excellence  references historyedit before edit in  cardinal health acquired pci headquarters philadelphia pennsylvania pci packaging coordinators inc is a pharmaceutical contract packing service for commercial and clinical packaging in  cardinal health acquired rp scherer corporation headquarters troy michigan robert pauli scherer founded the rp scherer corporation to commercialize his innovation of softgel encapsulation using the rotary die production process in  cardinal health acquired automatic liquid packaging inc headquarters woodstock ill whose blowfillseal technology allowed cardinal to enter the sterile product market cardinal health also acquired international processing corporation headquarters winchester kentucky for its advanced controlled drug release and coating manufacturing expertise in  cardinal health acquired magellan laboratories inc a company that specialized in product development expertise in  cardinal health acquired gala biotech headquarters middleton wisconsin gala biotech had established technologies surrounding gene insertion and the production of pharmaceutical proteins which became gpex® technology in the same year cardinal health also acquired intercare group plc broadening its global capabilities in europe in  cardinal health further expanded its reach in biotechnology and pharmaceutical markets through multiple other acquisitions formation of catalent in edit in  the pharmaceutical technologies and services segment of cardinal health was purchased by blackstone group and rebranded as catalent pharma solutions after  and initial public offeringedit in  the company acquired the molecular optimization platform optiform® from glaxosmithkline in  catalent acquired aptuit a clinical supply solutions company as part of the deal catalent gained three sites in the united states two sites in the united kingdom and one in singapore catalent also acquired all remaining shares for the rp scherer site in eberbach germany in  catalent pharmaceutical solutions continued the global expansion of its softgel capabilities through a joint venture with zhejiang jaing yuan tang biotechnology co a chinabased company and relthy laboratories in brazil also in  catalent created a new business unit advanced delivery technologies which focuses on innovative and proven drug delivery technologies optimizing the company’s multiple technologies crossplatform rd solutions and global commercial manufacturing network this is the current structure of catalent’s business which includes softgel technologies advanced delivery technologies and development  clinical services business units catalent announced its initial public offering on july   after raising more than  million catalent became a publicly traded company on the new york stock exchange nyse the company priced its  million shares of common stock at  apiece with a market capitalization of  billion the shares began trading on the nyse on july   under the ticker symbol ctlt and the offering closed on august   the proceeds of the offering went to the redemption of more than  million of catalent’s outstanding debt “this will allow the company to significantly reduce its interest expense enable future potential internal and external growth strategies and to continue our growthbiased investments into new technologies capabilities global development and manufacturing facilities and capacity” a company statement reported in september  the company acquired the contract drug development and clinical manufacturing company which specializes in early stage development and spray drying pharmatek laboratories in november  the company agreed to acquire canadian based accucaps industries both the strathroy on and windsor on locations will become the th and th softgel technology facilities under the catalent name corporate governanceedit senior managementedit position name since president  chief executive officer and director john r chiminski march  executive vice president and chief financial officer matthew walsh december  president development and clinical services wetteny joseph august  president softgel technologies aris gennadios september  president advanced delivery technologies barry littlejohns july  senior vice president chief information officer michael del priore december  senior vice president global sales  marketing william downie june  senior vice president quality product development and regulatory affairs sharon johnson august  senior vice president global operations stephen leonard june  senior vice president human resources lance miyamoto march  senior vice president general counsel steven fasman october  drug delivery technologiesedit catalents brand currently owns and operates the following drug delivery technologies predevelopment technologies optiform technology catalent micron technologies oral drug delivery technologies rp scherer softgel technology optigel technology optigel lock technology optigel micro technology optigel mini technology zydis technology osdrc optidose drug delivery technology optimelt technology optipact technology sterile technologies advasept technology biologics smartag technology gpex technology centers of excellenceedit catalent has designated the following locations as a center of excellence with the following specializations swindon united kingdom – zydis technology somerset new jersey – osdrc optidose drug delivery technology philadelphia pennsylvania – clinical supply services st petersburg florida – rp scherer softgel technology woodstock illinois – blowfillseal bfs technology winchester kentucky – advanced oral delivery technologies madison wisconsin – gpex technology research triangle park north carolina – inhalation referencesedit  a b c d e f g h i j k l m n the united states securities and exchange commission  form k washington dc catalent pharma solutions catalent pharma solutions retrieved    a b c catalent pharma solutions  catalent reports fourth quarter and fiscal year  results catalent pharma solutions retrieved    our locations catalentcom catalent inc retrieved  nov    a b c d e f cardinal healths timeline  cardinalhealthcom cardinalhealthcom retrieved  april    pci leads the market in healthcare packaging solutions pci services retrieved  april    a b catalent completes acquisition of r p scherer eberbach manufacturing chemist  march  retrieved  april    a b kuehn steven  october  container innovations prairie home pharmaceutical manufacturing retrieved  april    rp scherer to gain new drugdelivery business with acquisition of international processing corporation cmo cro pr newswire  december  retrieved  april    cardinal health to enhance drug development services with acquisition of gala biotech cardinal health inc pr newswire  oct  retrieved  april    cardinal health completes sale of pharmaceutical technologies and services segment to the blackstone group dublin ohio blackstone group  april    ohnesorge lauren k  january  catalent cements local footprint triangle business journal retrieved  april    catalent completes aptuit deal biopharmareportercom  february  retrieved  april    stanton dan  october  catalents brazilian acquisition supports global softgel strategy inpharmatechnologistcom retrieved  april    catalent creates new advanced delivery technologies business unit catalent inc pr web  july  retrieved  april    a b catalent issues initial public offering  pharmtechcom pharmaceutical technology sourcing and management  august  retrieved  april    catalent issues initial public offering catalentcom catalent inc retrieved  april    httpwwwgenengnewscomgennewshighlightscatalenttoacquirepharmatek  httpwwwcatalentcomindexphpnewseventsnewscatalentacquiresaccucapstoexpandsoftgeldevelopmentandmanufacturingcapabilitiesandcapacity  our leadership catalent catalent inc retrieved  nov    a b c catalent announces new optimized drug delivery technologies at cphl worldwideicse redorbit  october  retrieved  april    new optipact™ technology introduced by catalent catalent inc pr web  september  retrieved  april    a b catalent expands its technology offerings in biologics acquires redwood bioscience inc and the smartag™ technology platform catalent pharma solutions marketwatch  october  retrieved  april   retrieved from httpsenwikipediaorgwindexphptitlecatalentoldid categories companies based in somerset county new jerseypharmaceutical companies established in companies listed on the new york stock exchangepharmaceutical companies based in new jerseyhidden categories articles with a promotional tone from july all articles with a promotional toneuse dmy dates from april all articles with unsourced statementsarticles with unsourced statements from july  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  february  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view catalent  wikipedia catalent from wikipedia the free encyclopedia   redirected from catalent pharma solutions jump to navigation search this article contains content that is written like an advertisement please help improve it by removing promotional content and inappropriate external links and by adding encyclopedic content written from a neutral point of view july  learn how and when to remove this template message catalent inc type public company traded as nyse ctlt sp  component industry pharmaceutical biotechnology predecessor cardinal health pts founded  headquarters somerset new jersey usa number of locations  key people john chiminski president ceo matthew walsh executive vice president cfo services drug preformulation formulation analytical testing clinical and commercial manufacturing clinical packaging and supply chain solutions regulatory consulting revenue us billion  operating income us  million  net income us  million  number of employees   website wwwcatalentcom catalent inc catalent pharma solutions is a global provider of drug delivery technology and development solutions for drugs biologics and consumer health products headquartered in somerset new jersey catalent operates  locations across five continents producing more than  billion doses annually for nearly  customer products originally created through a series of acquisitions by cardinal health inc catalent became independent in  catalent promotes its ability to increase customers speed to market and its participation in nearly half of new drug entities approved by the food and drug administration in the last decade the company currently holds approximately  patents and patent applications and continues to expand its offerings through investments in emerging technologies in its fiscal year  ending june  catalent’s customers included  of the top  branded drug marketers  of the top  generics marketers  of the top  biologics marketers and  of the top  consumer health marketers globallycitation needed on july   catalent became a public company and is listed on the new york stock exchange nyse ctlt contents  history  before   formation of catalent in   after  and initial public offering  corporate governance  senior management  drug delivery technologies  centers of excellence  references historyedit before edit in  cardinal health acquired pci headquarters philadelphia pennsylvania pci packaging coordinators inc is a pharmaceutical contract packing service for commercial and clinical packaging in  cardinal health acquired rp scherer corporation headquarters troy michigan robert pauli scherer founded the rp scherer corporation to commercialize his innovation of softgel encapsulation using the rotary die production process in  cardinal health acquired automatic liquid packaging inc headquarters woodstock ill whose blowfillseal technology allowed cardinal to enter the sterile product market cardinal health also acquired international processing corporation headquarters winchester kentucky for its advanced controlled drug release and coating manufacturing expertise in  cardinal health acquired magellan laboratories inc a company that specialized in product development expertise in  cardinal health acquired gala biotech headquarters middleton wisconsin gala biotech had established technologies surrounding gene insertion and the production of pharmaceutical proteins which became gpex® technology in the same year cardinal health also acquired intercare group plc broadening its global capabilities in europe in  cardinal health further expanded its reach in biotechnology and pharmaceutical markets through multiple other acquisitions formation of catalent in edit in  the pharmaceutical technologies and services segment of cardinal health was purchased by blackstone group and rebranded as catalent pharma solutions after  and initial public offeringedit in  the company acquired the molecular optimization platform optiform® from glaxosmithkline in  catalent acquired aptuit a clinical supply solutions company as part of the deal catalent gained three sites in the united states two sites in the united kingdom and one in singapore catalent also acquired all remaining shares for the rp scherer site in eberbach germany in  catalent pharmaceutical solutions continued the global expansion of its softgel capabilities through a joint venture with zhejiang jaing yuan tang biotechnology co a chinabased company and relthy laboratories in brazil also in  catalent created a new business unit advanced delivery technologies which focuses on innovative and proven drug delivery technologies optimizing the company’s multiple technologies crossplatform rd solutions and global commercial manufacturing network this is the current structure of catalent’s business which includes softgel technologies advanced delivery technologies and development  clinical services business units catalent announced its initial public offering on july   after raising more than  million catalent became a publicly traded company on the new york stock exchange nyse the company priced its  million shares of common stock at  apiece with a market capitalization of  billion the shares began trading on the nyse on july   under the ticker symbol ctlt and the offering closed on august   the proceeds of the offering went to the redemption of more than  million of catalent’s outstanding debt “this will allow the company to significantly reduce its interest expense enable future potential internal and external growth strategies and to continue our growthbiased investments into new technologies capabilities global development and manufacturing facilities and capacity” a company statement reported in september  the company acquired the contract drug development and clinical manufacturing company which specializes in early stage development and spray drying pharmatek laboratories in november  the company agreed to acquire canadian based accucaps industries both the strathroy on and windsor on locations will become the th and th softgel technology facilities under the catalent name corporate governanceedit senior managementedit position name since president  chief executive officer and director john r chiminski march  executive vice president and chief financial officer matthew walsh december  president development and clinical services wetteny joseph august  president softgel technologies aris gennadios september  president advanced delivery technologies barry littlejohns july  senior vice president chief information officer michael del priore december  senior vice president global sales  marketing william downie june  senior vice president quality product development and regulatory affairs sharon johnson august  senior vice president global operations stephen leonard june  senior vice president human resources lance miyamoto march  senior vice president general counsel steven fasman october  drug delivery technologiesedit catalents brand currently owns and operates the following drug delivery technologies predevelopment technologies optiform technology catalent micron technologies oral drug delivery technologies rp scherer softgel technology optigel technology optigel lock technology optigel micro technology optigel mini technology zydis technology osdrc optidose drug delivery technology optimelt technology optipact technology sterile technologies advasept technology biologics smartag technology gpex technology centers of excellenceedit catalent has designated the following locations as a center of excellence with the following specializations swindon united kingdom – zydis technology somerset new jersey – osdrc optidose drug delivery technology philadelphia pennsylvania – clinical supply services st petersburg florida – rp scherer softgel technology woodstock illinois – blowfillseal bfs technology winchester kentucky – advanced oral delivery technologies madison wisconsin – gpex technology research triangle park north carolina – inhalation referencesedit  a b c d e f g h i j k l m n the united states securities and exchange commission  form k washington dc catalent pharma solutions catalent pharma solutions retrieved    a b c catalent pharma solutions  catalent reports fourth quarter and fiscal year  results catalent pharma solutions retrieved    our locations catalentcom catalent inc retrieved  nov    a b c d e f cardinal healths timeline  cardinalhealthcom cardinalhealthcom retrieved  april    pci leads the market in healthcare packaging solutions pci services retrieved  april    a b catalent completes acquisition of r p scherer eberbach manufacturing chemist  march  retrieved  april    a b kuehn steven  october  container innovations prairie home pharmaceutical manufacturing retrieved  april    rp scherer to gain new drugdelivery business with acquisition of international processing corporation cmo cro pr newswire  december  retrieved  april    cardinal health to enhance drug development services with acquisition of gala biotech cardinal health inc pr newswire  oct  retrieved  april    cardinal health completes sale of pharmaceutical technologies and services segment to the blackstone group dublin ohio blackstone group  april    ohnesorge lauren k  january  catalent cements local footprint triangle business journal retrieved  april    catalent completes aptuit deal biopharmareportercom  february  retrieved  april    stanton dan  october  catalents brazilian acquisition supports global softgel strategy inpharmatechnologistcom retrieved  april    catalent creates new advanced delivery technologies business unit catalent inc pr web  july  retrieved  april    a b catalent issues initial public offering  pharmtechcom pharmaceutical technology sourcing and management  august  retrieved  april    catalent issues initial public offering catalentcom catalent inc retrieved  april    httpwwwgenengnewscomgennewshighlightscatalenttoacquirepharmatek  httpwwwcatalentcomindexphpnewseventsnewscatalentacquiresaccucapstoexpandsoftgeldevelopmentandmanufacturingcapabilitiesandcapacity  our leadership catalent catalent inc retrieved  nov    a b c catalent announces new optimized drug delivery technologies at cphl worldwideicse redorbit  october  retrieved  april    new optipact™ technology introduced by catalent catalent inc pr web  september  retrieved  april    a b catalent expands its technology offerings in biologics acquires redwood bioscience inc and the smartag™ technology platform catalent pharma solutions marketwatch  october  retrieved  april   retrieved from httpsenwikipediaorgwindexphptitlecatalentoldid categories companies based in somerset county new jerseypharmaceutical companies established in companies listed on the new york stock exchangepharmaceutical companies based in new jerseyhidden categories articles with a promotional tone from july all articles with a promotional toneuse dmy dates from april all articles with unsourced statementsarticles with unsourced statements from july  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  february  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view catalent  wikipedia catalent from wikipedia the free encyclopedia   redirected from catalent pharma solutions jump to navigation search this article contains content that is written like an advertisement please help improve it by removing promotional content and inappropriate external links and by adding encyclopedic content written from a neutral point of view july  learn how and when to remove this template message catalent inc type public company traded as nyse ctlt sp  component industry pharmaceutical biotechnology predecessor cardinal health pts founded  headquarters somerset new jersey usa number of locations  key people john chiminski president ceo matthew walsh executive vice president cfo services drug preformulation formulation analytical testing clinical and commercial manufacturing clinical packaging and supply chain solutions regulatory consulting revenue us billion  operating income us  million  net income us  million  number of employees   website wwwcatalentcom catalent inc catalent pharma solutions is a global provider of drug delivery technology and development solutions for drugs biologics and consumer health products headquartered in somerset new jersey catalent operates  locations across five continents producing more than  billion doses annually for nearly  customer products originally created through a series of acquisitions by cardinal health inc catalent became independent in  catalent promotes its ability to increase customers speed to market and its participation in nearly half of new drug entities approved by the food and drug administration in the last decade the company currently holds approximately  patents and patent applications and continues to expand its offerings through investments in emerging technologies in its fiscal year  ending june  catalent’s customers included  of the top  branded drug marketers  of the top  generics marketers  of the top  biologics marketers and  of the top  consumer health marketers globallycitation needed on july   catalent became a public company and is listed on the new york stock exchange nyse ctlt contents  history  before   formation of catalent in   after  and initial public offering  corporate governance  senior management  drug delivery technologies  centers of excellence  references historyedit before edit in  cardinal health acquired pci headquarters philadelphia pennsylvania pci packaging coordinators inc is a pharmaceutical contract packing service for commercial and clinical packaging in  cardinal health acquired rp scherer corporation headquarters troy michigan robert pauli scherer founded the rp scherer corporation to commercialize his innovation of softgel encapsulation using the rotary die production process in  cardinal health acquired automatic liquid packaging inc headquarters woodstock ill whose blowfillseal technology allowed cardinal to enter the sterile product market cardinal health also acquired international processing corporation headquarters winchester kentucky for its advanced controlled drug release and coating manufacturing expertise in  cardinal health acquired magellan laboratories inc a company that specialized in product development expertise in  cardinal health acquired gala biotech headquarters middleton wisconsin gala biotech had established technologies surrounding gene insertion and the production of pharmaceutical proteins which became gpex® technology in the same year cardinal health also acquired intercare group plc broadening its global capabilities in europe in  cardinal health further expanded its reach in biotechnology and pharmaceutical markets through multiple other acquisitions formation of catalent in edit in  the pharmaceutical technologies and services segment of cardinal health was purchased by blackstone group and rebranded as catalent pharma solutions after  and initial public offeringedit in  the company acquired the molecular optimization platform optiform® from glaxosmithkline in  catalent acquired aptuit a clinical supply solutions company as part of the deal catalent gained three sites in the united states two sites in the united kingdom and one in singapore catalent also acquired all remaining shares for the rp scherer site in eberbach germany in  catalent pharmaceutical solutions continued the global expansion of its softgel capabilities through a joint venture with zhejiang jaing yuan tang biotechnology co a chinabased company and relthy laboratories in brazil also in  catalent created a new business unit advanced delivery technologies which focuses on innovative and proven drug delivery technologies optimizing the company’s multiple technologies crossplatform rd solutions and global commercial manufacturing network this is the current structure of catalent’s business which includes softgel technologies advanced delivery technologies and development  clinical services business units catalent announced its initial public offering on july   after raising more than  million catalent became a publicly traded company on the new york stock exchange nyse the company priced its  million shares of common stock at  apiece with a market capitalization of  billion the shares began trading on the nyse on july   under the ticker symbol ctlt and the offering closed on august   the proceeds of the offering went to the redemption of more than  million of catalent’s outstanding debt “this will allow the company to significantly reduce its interest expense enable future potential internal and external growth strategies and to continue our growthbiased investments into new technologies capabilities global development and manufacturing facilities and capacity” a company statement reported in september  the company acquired the contract drug development and clinical manufacturing company which specializes in early stage development and spray drying pharmatek laboratories in november  the company agreed to acquire canadian based accucaps industries both the strathroy on and windsor on locations will become the th and th softgel technology facilities under the catalent name corporate governanceedit senior managementedit position name since president  chief executive officer and director john r chiminski march  executive vice president and chief financial officer matthew walsh december  president development and clinical services wetteny joseph august  president softgel technologies aris gennadios september  president advanced delivery technologies barry littlejohns july  senior vice president chief information officer michael del priore december  senior vice president global sales  marketing william downie june  senior vice president quality product development and regulatory affairs sharon johnson august  senior vice president global operations stephen leonard june  senior vice president human resources lance miyamoto march  senior vice president general counsel steven fasman october  drug delivery technologiesedit catalents brand currently owns and operates the following drug delivery technologies predevelopment technologies optiform technology catalent micron technologies oral drug delivery technologies rp scherer softgel technology optigel technology optigel lock technology optigel micro technology optigel mini technology zydis technology osdrc optidose drug delivery technology optimelt technology optipact technology sterile technologies advasept technology biologics smartag technology gpex technology centers of excellenceedit catalent has designated the following locations as a center of excellence with the following specializations swindon united kingdom – zydis technology somerset new jersey – osdrc optidose drug delivery technology philadelphia pennsylvania – clinical supply services st petersburg florida – rp scherer softgel technology woodstock illinois – blowfillseal bfs technology winchester kentucky – advanced oral delivery technologies madison wisconsin – gpex technology research triangle park north carolina – inhalation referencesedit  a b c d e f g h i j k l m n the united states securities and exchange commission  form k washington dc catalent pharma solutions catalent pharma solutions retrieved    a b c catalent pharma solutions  catalent reports fourth quarter and fiscal year  results catalent pharma solutions retrieved    our locations catalentcom catalent inc retrieved  nov    a b c d e f cardinal healths timeline  cardinalhealthcom cardinalhealthcom retrieved  april    pci leads the market in healthcare packaging solutions pci services retrieved  april    a b catalent completes acquisition of r p scherer eberbach manufacturing chemist  march  retrieved  april    a b kuehn steven  october  container innovations prairie home pharmaceutical manufacturing retrieved  april    rp scherer to gain new drugdelivery business with acquisition of international processing corporation cmo cro pr newswire  december  retrieved  april    cardinal health to enhance drug development services with acquisition of gala biotech cardinal health inc pr newswire  oct  retrieved  april    cardinal health completes sale of pharmaceutical technologies and services segment to the blackstone group dublin ohio blackstone group  april    ohnesorge lauren k  january  catalent cements local footprint triangle business journal retrieved  april    catalent completes aptuit deal biopharmareportercom  february  retrieved  april    stanton dan  october  catalents brazilian acquisition supports global softgel strategy inpharmatechnologistcom retrieved  april    catalent creates new advanced delivery technologies business unit catalent inc pr web  july  retrieved  april    a b catalent issues initial public offering  pharmtechcom pharmaceutical technology sourcing and management  august  retrieved  april    catalent issues initial public offering catalentcom catalent inc retrieved  april    httpwwwgenengnewscomgennewshighlightscatalenttoacquirepharmatek  httpwwwcatalentcomindexphpnewseventsnewscatalentacquiresaccucapstoexpandsoftgeldevelopmentandmanufacturingcapabilitiesandcapacity  our leadership catalent catalent inc retrieved  nov    a b c catalent announces new optimized drug delivery technologies at cphl worldwideicse redorbit  october  retrieved  april    new optipact™ technology introduced by catalent catalent inc pr web  september  retrieved  april    a b catalent expands its technology offerings in biologics acquires redwood bioscience inc and the smartag™ technology platform catalent pharma solutions marketwatch  october  retrieved  april   retrieved from httpsenwikipediaorgwindexphptitlecatalentoldid categories companies based in somerset county new jerseypharmaceutical companies established in companies listed on the new york stock exchangepharmaceutical companies based in new jerseyhidden categories articles with a promotional tone from july all articles with a promotional toneuse dmy dates from april all articles with unsourced statementsarticles with unsourced statements from july  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  february  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view catalent  wikipedia catalent from wikipedia the free encyclopedia   redirected from catalent pharma solutions jump to navigation search this article contains content that is written like an advertisement please help improve it by removing promotional content and inappropriate external links and by adding encyclopedic content written from a neutral point of view july  learn how and when to remove this template message catalent inc type public company traded as nyse ctlt sp  component industry pharmaceutical biotechnology predecessor cardinal health pts founded  headquarters somerset new jersey usa number of locations  key people john chiminski president ceo matthew walsh executive vice president cfo services drug preformulation formulation analytical testing clinical and commercial manufacturing clinical packaging and supply chain solutions regulatory consulting revenue us billion  operating income us  million  net income us  million  number of employees   website wwwcatalentcom catalent inc catalent pharma solutions is a global provider of drug delivery technology and development solutions for drugs biologics and consumer health products headquartered in somerset new jersey catalent operates  locations across five continents producing more than  billion doses annually for nearly  customer products originally created through a series of acquisitions by cardinal health inc catalent became independent in  catalent promotes its ability to increase customers speed to market and its participation in nearly half of new drug entities approved by the food and drug administration in the last decade the company currently holds approximately  patents and patent applications and continues to expand its offerings through investments in emerging technologies in its fiscal year  ending june  catalent’s customers included  of the top  branded drug marketers  of the top  generics marketers  of the top  biologics marketers and  of the top  consumer health marketers globallycitation needed on july   catalent became a public company and is listed on the new york stock exchange nyse ctlt contents  history  before   formation of catalent in   after  and initial public offering  corporate governance  senior management  drug delivery technologies  centers of excellence  references historyedit before edit in  cardinal health acquired pci headquarters philadelphia pennsylvania pci packaging coordinators inc is a pharmaceutical contract packing service for commercial and clinical packaging in  cardinal health acquired rp scherer corporation headquarters troy michigan robert pauli scherer founded the rp scherer corporation to commercialize his innovation of softgel encapsulation using the rotary die production process in  cardinal health acquired automatic liquid packaging inc headquarters woodstock ill whose blowfillseal technology allowed cardinal to enter the sterile product market cardinal health also acquired international processing corporation headquarters winchester kentucky for its advanced controlled drug release and coating manufacturing expertise in  cardinal health acquired magellan laboratories inc a company that specialized in product development expertise in  cardinal health acquired gala biotech headquarters middleton wisconsin gala biotech had established technologies surrounding gene insertion and the production of pharmaceutical proteins which became gpex® technology in the same year cardinal health also acquired intercare group plc broadening its global capabilities in europe in  cardinal health further expanded its reach in biotechnology and pharmaceutical markets through multiple other acquisitions formation of catalent in edit in  the pharmaceutical technologies and services segment of cardinal health was purchased by blackstone group and rebranded as catalent pharma solutions after  and initial public offeringedit in  the company acquired the molecular optimization platform optiform® from glaxosmithkline in  catalent acquired aptuit a clinical supply solutions company as part of the deal catalent gained three sites in the united states two sites in the united kingdom and one in singapore catalent also acquired all remaining shares for the rp scherer site in eberbach germany in  catalent pharmaceutical solutions continued the global expansion of its softgel capabilities through a joint venture with zhejiang jaing yuan tang biotechnology co a chinabased company and relthy laboratories in brazil also in  catalent created a new business unit advanced delivery technologies which focuses on innovative and proven drug delivery technologies optimizing the company’s multiple technologies crossplatform rd solutions and global commercial manufacturing network this is the current structure of catalent’s business which includes softgel technologies advanced delivery technologies and development  clinical services business units catalent announced its initial public offering on july   after raising more than  million catalent became a publicly traded company on the new york stock exchange nyse the company priced its  million shares of common stock at  apiece with a market capitalization of  billion the shares began trading on the nyse on july   under the ticker symbol ctlt and the offering closed on august   the proceeds of the offering went to the redemption of more than  million of catalent’s outstanding debt “this will allow the company to significantly reduce its interest expense enable future potential internal and external growth strategies and to continue our growthbiased investments into new technologies capabilities global development and manufacturing facilities and capacity” a company statement reported in september  the company acquired the contract drug development and clinical manufacturing company which specializes in early stage development and spray drying pharmatek laboratories in november  the company agreed to acquire canadian based accucaps industries both the strathroy on and windsor on locations will become the th and th softgel technology facilities under the catalent name corporate governanceedit senior managementedit position name since president  chief executive officer and director john r chiminski march  executive vice president and chief financial officer matthew walsh december  president development and clinical services wetteny joseph august  president softgel technologies aris gennadios september  president advanced delivery technologies barry littlejohns july  senior vice president chief information officer michael del priore december  senior vice president global sales  marketing william downie june  senior vice president quality product development and regulatory affairs sharon johnson august  senior vice president global operations stephen leonard june  senior vice president human resources lance miyamoto march  senior vice president general counsel steven fasman october  drug delivery technologiesedit catalents brand currently owns and operates the following drug delivery technologies predevelopment technologies optiform technology catalent micron technologies oral drug delivery technologies rp scherer softgel technology optigel technology optigel lock technology optigel micro technology optigel mini technology zydis technology osdrc optidose drug delivery technology optimelt technology optipact technology sterile technologies advasept technology biologics smartag technology gpex technology centers of excellenceedit catalent has designated the following locations as a center of excellence with the following specializations swindon united kingdom – zydis technology somerset new jersey – osdrc optidose drug delivery technology philadelphia pennsylvania – clinical supply services st petersburg florida – rp scherer softgel technology woodstock illinois – blowfillseal bfs technology winchester kentucky – advanced oral delivery technologies madison wisconsin – gpex technology research triangle park north carolina – inhalation referencesedit  a b c d e f g h i j k l m n the united states securities and exchange commission  form k washington dc catalent pharma solutions catalent pharma solutions retrieved    a b c catalent pharma solutions  catalent reports fourth quarter and fiscal year  results catalent pharma solutions retrieved    our locations catalentcom catalent inc retrieved  nov    a b c d e f cardinal healths timeline  cardinalhealthcom cardinalhealthcom retrieved  april    pci leads the market in healthcare packaging solutions pci services retrieved  april    a b catalent completes acquisition of r p scherer eberbach manufacturing chemist  march  retrieved  april    a b kuehn steven  october  container innovations prairie home pharmaceutical manufacturing retrieved  april    rp scherer to gain new drugdelivery business with acquisition of international processing corporation cmo cro pr newswire  december  retrieved  april    cardinal health to enhance drug development services with acquisition of gala biotech cardinal health inc pr newswire  oct  retrieved  april    cardinal health completes sale of pharmaceutical technologies and services segment to the blackstone group dublin ohio blackstone group  april    ohnesorge lauren k  january  catalent cements local footprint triangle business journal retrieved  april    catalent completes aptuit deal biopharmareportercom  february  retrieved  april    stanton dan  october  catalents brazilian acquisition supports global softgel strategy inpharmatechnologistcom retrieved  april    catalent creates new advanced delivery technologies business unit catalent inc pr web  july  retrieved  april    a b catalent issues initial public offering  pharmtechcom pharmaceutical technology sourcing and management  august  retrieved  april    catalent issues initial public offering catalentcom catalent inc retrieved  april    httpwwwgenengnewscomgennewshighlightscatalenttoacquirepharmatek  httpwwwcatalentcomindexphpnewseventsnewscatalentacquiresaccucapstoexpandsoftgeldevelopmentandmanufacturingcapabilitiesandcapacity  our leadership catalent catalent inc retrieved  nov    a b c catalent announces new optimized drug delivery technologies at cphl worldwideicse redorbit  october  retrieved  april    new optipact™ technology introduced by catalent catalent inc pr web  september  retrieved  april    a b catalent expands its technology offerings in biologics acquires redwood bioscience inc and the smartag™ technology platform catalent pharma solutions marketwatch  october  retrieved  april   retrieved from httpsenwikipediaorgwindexphptitlecatalentoldid categories companies based in somerset county new jerseypharmaceutical companies established in companies listed on the new york stock exchangepharmaceutical companies based in new jerseyhidden categories articles with a promotional tone from july all articles with a promotional toneuse dmy dates from april all articles with unsourced statementsarticles with unsourced statements from july  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  february  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view catalent inc to present at the jefferies  healthcare conferencehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets closedsp  dow  nasdaq catalent inc to present at the jefferies  healthcare conferencebusiness wiremay  reblogsharetweetsharesomerset njbusiness wirecatalent inc ctlt the leading global provider of advanced delivery technologies and development solutions for drugs biologics and consumer health products today announced that matthew walsh executive vice president  chief financial officer will present at the jefferies  healthcare conference at  am edt on thursday june   in new york nya live webcast of the presentation will be accessible through the company’s website at httpinvestorcatalentcom and will be available for replay following the eventabout catalent inccatalent is the leading global provider of advanced delivery technologies and development solutions for drugs biologics and consumer health products with over  years serving the industry catalent has proven expertise in bringing more customer products to market faster enhancing product performance and ensuring reliable clinical and commercial product supply catalent employs approximately  people including over  scientists at more than  facilities across  continents and in fiscal  generated  billion in annual revenue catalent is headquartered in somerset nj for more information visit wwwcatalentcommore products better treatments reliably supplied™view source version on businesswirecom httpwwwbusinesswirecomnewshomeenreblogsharetweetsharerecently viewedyour list is emptywhat to read nextsean hannity responds to claim he ran up a  tab at trumps hotel after flying in a yearold lobster from mainebusiness insiderengineer finds pattern makes millions in stocksmoney morningsponsoredmarine dog with cancer gets tearfilled farewellassociated presstrump’s unwitting legacy could be universal health coverageyahoo financetwitter is only famous now because of president trump nyse traderyahoo finance videodiscover it  out of  avg by k customersdiscover cardsponsoredrollsroyce motor ceo we’re not in the auto business we’re in the luxury businessyahoo financeamazon ploughs ahead with high sales and spending profit plungesreutersgop senators hold press conference to demand assurances that gop health plan does not become lawbusiness insiderzuckerberg wifes ambitious secret finally exposedunewzmesponsoredrepublicans kill the border taxyahoo financeamazon could be the first trillion dollar company nyse traderyahoo finance videohow grocers feel about amazon there was a lot of fear before theres a lot more fear nowyahoo finance bitcoin jackpot could explode by july agora financialsponsoredbuffalo wild wings is killing one of customers favorite dealsbusiness insidermattis was on vacation when trump tweeted transgender ban and he was reportedly appalled by itbusiness insidersean spicer resigns as white house press secretarykevin the trump experiment clearly has not worked i know all you trump supporters thought this was the washington shakeup we needed and that some savvy businessman would be an effective president the problem is that you chose donald trump a person devoid of ethics and only interested in himself and winning the man is not intelligent cant understand healthcare and therefore cant participate in the policy debate and clearly doesnt understand the law and constitution you got your supreme court nominee  beyond that trump is a complete train wreckjoin the conversation  k catalent pharma solutions inc private company information  bloomberg july    pm et life sciences tools and services company overview of catalent pharma solutions inc snapshot people company overview catalent pharma solutions inc provides development solutions and delivery technologies for drugs biologics and consumer health products the company’s development and clinical services segment offers manufacturing packaging storage and inventory management services for drugs and biologics in clinical trials this segment also provides analytical chemical and cellbased testing and scientific services respiratory products formulation and manufacturing regulatory consulting and bioanalytical testing for biologic products its oral technologies segment offers oral delivery technologies including formulation development and manufacturing services for the oral dose forms comprising p catalent pharma solutions inc provides development solutions and delivery technologies for drugs biologics and consumer health products the company’s development and clinical services segment offers manufacturing packaging storage and inventory management services for drugs and biologics in clinical trials this segment also provides analytical chemical and cellbased testing and scientific services respiratory products formulation and manufacturing regulatory consulting and bioanalytical testing for biologic products its oral technologies segment offers oral delivery technologies including formulation development and manufacturing services for the oral dose forms comprising prescription and consumer health products this segment provides formulation development and manufacturing services for soft gelatin capsules modified release and immediate release solid oral technology products and fastdissolve tablets and proprietary and conventional controlled release products the medication delivery solutions segment offers formulation development and manufacturing services for prefilled syringes and other injectable formats blowfillseal unit dose development and manufacturing services and biologic cell line development and manufacturing services it serves pharmaceutical and biotechnology and consumer health companies in the united states europe and internationally the company is headquartered in somerset new jersey catalent pharma solutions inc operates as a subsidiary of catalent inc detailed description  schoolhouse roadsomerset nj united states employees phone  fax  wwwcatalentcom key executives for catalent pharma solutions inc mr john r chiminski chief executive officer president and director age  mr matthew m walsh chief financial officer principal accounting officer and executive vice president age  mr stephen leonard senior vice president of global operations age  mr barry b littlejohns president of advanced delivery technologies age  mr mark bisset president of catalent asia pacific compensation as of fiscal year  catalent pharma solutions inc key developments catalent pharma solutions appoints matthew stober to the advisory board mar   catalent pharma solutions announced that matthew stober has been appointed to the advisory board of the companys biologics business mr stober will join the boards founding members carolyn bertozzi phd barry buckland phd michael buckley phd daniel r marshak phd and edward r robinson mr stober is a corporate officer member of the executive committee and president of global operations at smith  nephew he has nearly  years experience within pharmaceutical manufacturing and operations most recently serving as senior vice president of operations corporate officer and member of the executive committee at hospira pharmaceuticals catalent pharma solutions inc presents at th annual jp morgan healthcare conference jan  am jan   catalent pharma solutions inc presents at th annual jp morgan healthcare conference jan  am venue westin st francis hotel  powell street san francisco ca  united states catalent pharma solutions inc presents at th annual conference biotech showcase jan dec   catalent pharma solutions inc presents at th annual conference biotech showcase jan  venue hilton san francisco union square  ofarrell street san francisco ca  united states similar private companies by industry company name region x genomics inc united states g clinical inc united states aapharmasyn llc united states abiant inc united states abiobot inc united states recent private companies transactions typedate target mergeracquisition november   accucaps industries limited mergeracquisition september   pharmatek laboratories inc request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact catalent pharma solutions inc please visit wwwcatalentcom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close catalent inc  cmocro home about us news compare  contrast cro wizard add your service contact login catalent inc catalent inc is the leading global provider of advanced delivery technologies and development solutions for drugs biologics and consumer health products with over  years serving the industry catalent has proven expertise in bringing more customer products to market faster enhancing product performance and ensuring reliable clinical and commercial product supplyacquired companies pharmatek laboratories inc r p scherer gmbh und co kg micron technologies relthy laboratorios ltd redwood bioscience inc year foundedphone faxemailinfocatalentcomwebsitehttpwwwcatalentcomaddress schoolhouse road somerset nj  overviewservice informationfacilitiescompany news business sectorssectors diagnosticsdrug deliverygenericsmedical devicenutraceuticalsotcpharmabiotechveterinary development stagesdevelopment stages clinicalcommercialdiscoveryphase phase phase preclinical molecule typesmolecule types biologicsantibodycell therapiespeptideproteinviral vectorssmall moleculesynthetic polymers product typesproduct type biopharmaceuticalscombination productscontrolled substancesdrug conjugatesantibody drug conugatesbioconjugatespegprodrugshormonevaccineadjuvant routeroute categories buccalinhalationnasalinjectableinjection iminjection infusioninjection intradermalinjection scopthalmicoralrectalsublingualtopicalvaginal analyticalsample type apicleaningvalidationcontainerclosuredosage formintermediateraw materialtoxicologyservice type devicemethodsmethod developmentmethod transfermethod validationprocess analytical technologyreference standard certificationstructure elucidationtest  releaseinvitro release testinglot and batch release testingtestinstrumentallcms analysisthermal analysesdscxray powder diffraction analysistests  dissolutiondissolution app iiitests  physicaldisintegrationparticle sizephysical testingtests  proteinpeptidednaoligotests  purity relatedassaypotencycontent uniformityelemental analysisforced degradationimpdeg identificationimpdeg quantitationtests  stabilityaccelerated stabilityichcommercial stability storageichcommercial stability testingphotostabilitystability storage iiistability testing iiitestspackaging relatedophthalmic formulationpackagingtopical formulationpackaging compatibilitytestsanalysis  othercomparator analysiscompendial testingdeformulationwet chemistry bioanalyticalspecific servicesbioanalytical antibodyprotein analysisflow cytometrymetabolite identificationtissuecell storage clinicalclinical services provided project managementregulatoryqualitysafety drug substance or apiapi process capabilities biological servicescell bank manufacturingprocess developmentscaleupapi related services reagents and morereference standards formulationformulation process capabilities coatingenteric coatingfilm coatingfluid bed coatingdevelopment and manufacturing servicesformulation developmentglptox supportmanufacturinggmp clinical phase ich batchesscale upvalidation batchesprocess developmentdryingfluid bed dryinggranulationfluid bed granulationwet granulationparticle and powder engineeringformulation type inhalation formulationsinjectableinjectable lyophilizedinjectable solutionnasal formulationsoralbuccalsublingualfixed dose combination productsinsoluble drug formulationsoral amorphoushot melt extrusion hmesolid solutionsoral seddswater insoluble formulation screeningodtoral fast melt tabletsoral emulsionsoral encapsulationapi in capsuleapi in capsulexcelodoseoral capsule iroral hard capsule liquid filloral softgel capsuleoral liquidsoral solsusporal tabletsoral ir tabletsoral mr tabletoral multilayer mr tabletsoral osmotic mr tabletspelletspowdersoral pellets irtaste maskingpediatric formulationstopicalvaginalsuppository medical and drug delivery devicesdrug delivery devices inhalation and nasal devicesactuation indicatorsdose countersdpimdinebulizerinjection devices and pumpsprefilled syringesafety syringesspecialty syringes microbiologyspecific services  microbiology antiseptics and antibiotic testingbacterial endotoxin testingbioburden testingbiological indicator analysisbiosafetyprion clearancecleanroom validationscompendial testingcontainer closure testingdisinfectant efficacy testingenvironmental assessmentsenvironmental monitoringfilter validationfungicidal activitygrowth promotion testingmedia fillsmicrobial identificationmicrobial limit testingminimum bactericidal concentrationminimum inhibitory concentrationmycoplasma testingparticulate matter usppcrpreservative effectiveness testingproduct release servicespyrogen testingsterility testingsterilization validationswater testing usp packaging filling labeling and supply chainspecific services  packaging filling and labelling labelling and insertsblindinginsertsoutsertslabel design and printingoverencapsulationpackaging capabilitiesanticounterfitting  serialization solutionsbar codingchildresistantpackage design and toolingpackaging identification and sourcingpackaging validationsecondary packagingpackaging suppliesfolding cartonsprimary package filling servicesasepticsterile fillformfillsealprimary package fillinggeneralstick packssupply chain management cold chain managementdistributionimportexportinventory managementproduct storagerefrigirated product handling pharmacokineticsservice types adme adme computer predictionpkpd modellingdrugdrug interactions preformulationpreformulation services accelerated stabilityamorphous characterizationbcs classificationcolligative propertiescrystallization process developmentdegradation kineticsexcipient compatibilityforced degradation studieshot stage meltinghydrates and solvateshygroscopicityintrinsic dissolutionmelting pointmicroscopymoisture contentparticle size measurements partition coefficient logpphrate profilesphysical propertiespka dissociation constantpolymorphpowder flowabilitypowder surface characterizationprotein preformulationraman mappingrheologyviscositysalt formationsem microscopysolid state characterizationsolubilityspecific gravitysurfaceinterfacial tensionthermal analysesdsc regulatoryregulatory services andablacmcindctaidenda singaporejapanitalygermanyfranceeurope westerneurope northerneurope beneluxchinabrazilbelgiumaustraliaasia southernasia south easternasia easternargentinaamericas southamericas northernamericas latinswitzerlandunited kingdomuruguayusa  catalent launches new optiform solution suite to offer quick and efficient path from latestage discovery to phase i clinical trials pfizer partners with catalent for the manufacture of advil liquigels minis catalent provides commercial manufacturing of lexicon pharmaceuticals orphan drug xermelo following fda approval pharmatek adds further cgmp spray drying capacity in response to demand for improved pharmaceutical solubility catalent expands kansas city clinical storage  secondary packaging capabilities to meet growing demand for cold chain services catalent biologics collaborates with path malaria vaccine initiative to create antibodies for malaria vaccine research and development catalent becomes first cdmo to join pharmaceutical supply chain initiative catalent to provide fill  finish services for commercial supply of samsung bioepis biosimilar therapy catalent biologics announces agreement with moderna therapeutics catalent to acquire pharmatek adding expanded drug development services and spray drying technology catalent launches fastchain demand led clinical supply solution to meet increasing need for speed  flexibility in global clinical trials catalent introduces peelid safe storage label to improve storage and retrieval of patient kits catalent wins prestigious editors choice award at interphex for its optiform solution suite platform catalent working to restart production at french facility catalent quadruples cold chain capacity at clinical supply facility in shanghai china catalent announces new president of clinical supply services business catalent expands packaging capabilities in singapore to complement its asia pacific clinical supply network catalent announces the expansion of its advanced aseptic glassfree injectable platform with new advasept lock delivery technology catalent acquires pharmapak australia catalent expands european clinical packaging capabilities highlighting growing industry need for specialty handling catalent pharma solutions further expands its high potency handling capability catalent expands integrated softgel operations through coating  packaging investment in eberbach germany catalent biologics and mgc pharma announce partnership for biomanufacturing in asia catalent acquires micron technologies catalent expands highly potent and cytotoxic clinical packaging capabilities at kansas city campus new optipact technology introduced by catalent catalent and minomic collaborate to bring new prostate cancer treatment to market catalent launches advasepttm advanced aseptic technology for glassfree delivery of injectable drugs catalent announces agreement for one of the first regenerative therapies to employ ips cells in humans with cira kyoto university  catalents clinical trial supply facility in shanghai china opens for business catalent and biota pharmaceuticals expand their alliance catalent and umn pharma announce collaboration for biosimilar development and production in japan catalent pharma solutions to supply the newly approved exelixis cometriq cabozantinib in the us market  catalent announces global alliance with parexel to streamline clinical trial material supply chain process basf and catalent join forces to solve bioavailability challenges catalent plans to increase biologic development and manufacturing capabilities catalent expands analytical services capabilities with a new lab in swindon uk catalent pharma solutions expert to present a case study of a phase  trial on overcoming emerging markets and cold chain challenges  catalent pharma solutions announces partnership with toyobo biologics inc to copromote gpex technology in japanese market  catalent invests in expanding clinical cevec and catalent pharma solutions offer joint cell line development service  cevec and catalent pharma solutions offer joint cell line development service amarin announces global supply network for amr catalent agrees to sell printed components business catalent announces partnership with nuron biotech to provide sterile delivery and supply of ms treatment in phase iii clinical study catalent pharma solutions clinical supply continues to invest in automation to drive high quality service and improve efficiencies worldclass optiform compound optimization platform now available to the broad scientific community from catalent pharma solutions tracelink and catalent deliver innovative solutions to enhance partners pharmaceutical supply chains catalents printed components plant in dublin is the first secondary packaging facility in ireland to achieve iso  certification catalent pharma solutions enters a strategic alliance with endotis pharma catalent expands capabilities in testing for melamine in food and medicinal products catalent offers the anticounterfeiting digitrack digital watermarking system to track trace and authenticate catalent pharma solutions supports global industry response to hn flu outbreak bavaria industriekapital ag announces acquisition of osny oral dose manufacturing business from catalent catalent pharma solutions announces printed components business changes development and manufacturing and cell line sale agreements with catalent home page about us news comparecontrast cro wizard add your service contact copyright   wwwcmocrocom all rights reserved warning close home  catalent sign up now to stay current with the latest news and insights subscribe now development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us catalent is the  partner in helping pharmaceutical biotech and consumer health innovators develop deliver and supply superior products that improve people’s lives play video how can we work together drug development delivery  supply biologics consumer health explore the range of delivery options for your molecule this web tool enables drug development professionals to solve one of the most challenging aspects in drug development determining the optimal finished dose suited to your specific product requirements target indication and molecule properties learn more how can we work together drug development delivery  supply biologics consumer health why catalent unrivaled experience expertise and a track recordof market successes on a global scalelearn more about us how can we work together drug development delivery  supply biologics consumer health latest news pfizer partners with catalent on the new advil® liquigels® minis launch catalent launches expanded optiform® solution suite a complete early development offering catalent pharma solutions has launched the expanded optiform® solution suite platform extending the scope of the service to efficiently guide a molecule’s progress from candidate selection to phase i clinic supplies using integrated capabilities and a datadriven process for faster early phase development  learn more our solutions improve your treatments at every stage catalent shares the passion to unlock the potential of your product offering comprehensive solutions and superior technologies for oral biologic sterile and inhaled dose forms at every phase  from preclinical formulation through commercial supply clinical supply services need to accelerate your clinical trial partner with a leading global provider of integrated clinical trial supply solutions from clinical manufacturing packaging and comparator procurement to global logistics we can help optiform® pro web tool what dose form would work the best for your challenging molecule our tool can provide multiple sciencebased options try it now our facilities around the world enable us to tailor a solution to fit your needs see all of our locationsor visit our local language siteschinajapansouth america spanishportuguese news events twitter catalent applied drug delivery institute appoints jim spavins to advisory board jul   catalent applied drug delivery institute partners with rutgers university jul   catalent launches new optiform® solution suite jul   aug  expofybi  buenos aires argentina sep  vitafoods asia singapore asia sep  controlled  modified drug release philadelphia pa view all view all follow us catalentpharma resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement catalent  wikipedia catalent from wikipedia the free encyclopedia jump to navigation search this article contains content that is written like an advertisement please help improve it by removing promotional content and inappropriate external links and by adding encyclopedic content written from a neutral point of view july  learn how and when to remove this template message catalent inc type public company traded as nyse ctlt sp  component industry pharmaceutical biotechnology predecessor cardinal health pts founded  headquarters somerset new jersey usa number of locations  key people john chiminski president ceo matthew walsh executive vice president cfo services drug preformulation formulation analytical testing clinical and commercial manufacturing clinical packaging and supply chain solutions regulatory consulting revenue us billion  operating income us  million  net income us  million  number of employees   website wwwcatalentcom catalent inc catalent pharma solutions is a global provider of drug delivery technology and development solutions for drugs biologics and consumer health products headquartered in somerset new jersey catalent operates  locations across five continents producing more than  billion doses annually for nearly  customer products originally created through a series of acquisitions by cardinal health inc catalent became independent in  catalent promotes its ability to increase customers speed to market and its participation in nearly half of new drug entities approved by the food and drug administration in the last decade the company currently holds approximately  patents and patent applications and continues to expand its offerings through investments in emerging technologies in its fiscal year  ending june  catalent’s customers included  of the top  branded drug marketers  of the top  generics marketers  of the top  biologics marketers and  of the top  consumer health marketers globallycitation needed on july   catalent became a public company and is listed on the new york stock exchange nyse ctlt contents  history  before   formation of catalent in   after  and initial public offering  corporate governance  senior management  drug delivery technologies  centers of excellence  references historyedit before edit in  cardinal health acquired pci headquarters philadelphia pennsylvania pci packaging coordinators inc is a pharmaceutical contract packing service for commercial and clinical packaging in  cardinal health acquired rp scherer corporation headquarters troy michigan robert pauli scherer founded the rp scherer corporation to commercialize his innovation of softgel encapsulation using the rotary die production process in  cardinal health acquired automatic liquid packaging inc headquarters woodstock ill whose blowfillseal technology allowed cardinal to enter the sterile product market cardinal health also acquired international processing corporation headquarters winchester kentucky for its advanced controlled drug release and coating manufacturing expertise in  cardinal health acquired magellan laboratories inc a company that specialized in product development expertise in  cardinal health acquired gala biotech headquarters middleton wisconsin gala biotech had established technologies surrounding gene insertion and the production of pharmaceutical proteins which became gpex® technology in the same year cardinal health also acquired intercare group plc broadening its global capabilities in europe in  cardinal health further expanded its reach in biotechnology and pharmaceutical markets through multiple other acquisitions formation of catalent in edit in  the pharmaceutical technologies and services segment of cardinal health was purchased by blackstone group and rebranded as catalent pharma solutions after  and initial public offeringedit in  the company acquired the molecular optimization platform optiform® from glaxosmithkline in  catalent acquired aptuit a clinical supply solutions company as part of the deal catalent gained three sites in the united states two sites in the united kingdom and one in singapore catalent also acquired all remaining shares for the rp scherer site in eberbach germany in  catalent pharmaceutical solutions continued the global expansion of its softgel capabilities through a joint venture with zhejiang jaing yuan tang biotechnology co a chinabased company and relthy laboratories in brazil also in  catalent created a new business unit advanced delivery technologies which focuses on innovative and proven drug delivery technologies optimizing the company’s multiple technologies crossplatform rd solutions and global commercial manufacturing network this is the current structure of catalent’s business which includes softgel technologies advanced delivery technologies and development  clinical services business units catalent announced its initial public offering on july   after raising more than  million catalent became a publicly traded company on the new york stock exchange nyse the company priced its  million shares of common stock at  apiece with a market capitalization of  billion the shares began trading on the nyse on july   under the ticker symbol ctlt and the offering closed on august   the proceeds of the offering went to the redemption of more than  million of catalent’s outstanding debt “this will allow the company to significantly reduce its interest expense enable future potential internal and external growth strategies and to continue our growthbiased investments into new technologies capabilities global development and manufacturing facilities and capacity” a company statement reported in september  the company acquired the contract drug development and clinical manufacturing company which specializes in early stage development and spray drying pharmatek laboratories in november  the company agreed to acquire canadian based accucaps industries both the strathroy on and windsor on locations will become the th and th softgel technology facilities under the catalent name corporate governanceedit senior managementedit position name since president  chief executive officer and director john r chiminski march  executive vice president and chief financial officer matthew walsh december  president development and clinical services wetteny joseph august  president softgel technologies aris gennadios september  president advanced delivery technologies barry littlejohns july  senior vice president chief information officer michael del priore december  senior vice president global sales  marketing william downie june  senior vice president quality product development and regulatory affairs sharon johnson august  senior vice president global operations stephen leonard june  senior vice president human resources lance miyamoto march  senior vice president general counsel steven fasman october  drug delivery technologiesedit catalents brand currently owns and operates the following drug delivery technologies predevelopment technologies optiform technology catalent micron technologies oral drug delivery technologies rp scherer softgel technology optigel technology optigel lock technology optigel micro technology optigel mini technology zydis technology osdrc optidose drug delivery technology optimelt technology optipact technology sterile technologies advasept technology biologics smartag technology gpex technology centers of excellenceedit catalent has designated the following locations as a center of excellence with the following specializations swindon united kingdom – zydis technology somerset new jersey – osdrc optidose drug delivery technology philadelphia pennsylvania – clinical supply services st petersburg florida – rp scherer softgel technology woodstock illinois – blowfillseal bfs technology winchester kentucky – advanced oral delivery technologies madison wisconsin – gpex technology research triangle park north carolina – inhalation referencesedit  a b c d e f g h i j k l m n the united states securities and exchange commission  form k washington dc catalent pharma solutions catalent pharma solutions retrieved    a b c catalent pharma solutions  catalent reports fourth quarter and fiscal year  results catalent pharma solutions retrieved    our locations catalentcom catalent inc retrieved  nov    a b c d e f cardinal healths timeline  cardinalhealthcom cardinalhealthcom retrieved  april    pci leads the market in healthcare packaging solutions pci services retrieved  april    a b catalent completes acquisition of r p scherer eberbach manufacturing chemist  march  retrieved  april    a b kuehn steven  october  container innovations prairie home pharmaceutical manufacturing retrieved  april    rp scherer to gain new drugdelivery business with acquisition of international processing corporation cmo cro pr newswire  december  retrieved  april    cardinal health to enhance drug development services with acquisition of gala biotech cardinal health inc pr newswire  oct  retrieved  april    cardinal health completes sale of pharmaceutical technologies and services segment to the blackstone group dublin ohio blackstone group  april    ohnesorge lauren k  january  catalent cements local footprint triangle business journal retrieved  april    catalent completes aptuit deal biopharmareportercom  february  retrieved  april    stanton dan  october  catalents brazilian acquisition supports global softgel strategy inpharmatechnologistcom retrieved  april    catalent creates new advanced delivery technologies business unit catalent inc pr web  july  retrieved  april    a b catalent issues initial public offering  pharmtechcom pharmaceutical technology sourcing and management  august  retrieved  april    catalent issues initial public offering catalentcom catalent inc retrieved  april    httpwwwgenengnewscomgennewshighlightscatalenttoacquirepharmatek  httpwwwcatalentcomindexphpnewseventsnewscatalentacquiresaccucapstoexpandsoftgeldevelopmentandmanufacturingcapabilitiesandcapacity  our leadership catalent catalent inc retrieved  nov    a b c catalent announces new optimized drug delivery technologies at cphl worldwideicse redorbit  october  retrieved  april    new optipact™ technology introduced by catalent catalent inc pr web  september  retrieved  april    a b catalent expands its technology offerings in biologics acquires redwood bioscience inc and the smartag™ technology platform catalent pharma solutions marketwatch  october  retrieved  april   retrieved from httpsenwikipediaorgwindexphptitlecatalentoldid categories companies based in somerset county new jerseypharmaceutical companies established in companies listed on the new york stock exchangepharmaceutical companies based in new jerseyhidden categories articles with a promotional tone from july all articles with a promotional toneuse dmy dates from april all articles with unsourced statementsarticles with unsourced statements from july  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  february  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view creative commons — attributionsharealike  unported — cc bysa  skip to content menu help us build a vibrant collaborative global commons donate now creative commons creative commons license deed attributionsharealike  unported cc bysa  this is a humanreadable summary of and not a substitute for the license disclaimer you are free to share — copy and redistribute the material in any medium or format adapt — remix transform and build upon the material for any purpose even commercially the licensor cannot revoke these freedoms as long as you follow the license terms under the following terms attribution — you must give appropriate credit provide a link to the license and indicate if changes were made you may do so in any reasonable manner but not in any way that suggests the licensor endorses you or your use attribute this work sharealike — if you remix transform or build upon the material you must distribute your contributions under the same license as the original no additional restrictions — you may not apply legal terms or technological measures that legally restrict others from doing anything the license permits notices you do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation no warranties are given the license may not give you all of the permissions necessary for your intended use for example other rights such as publicity privacy or moral rights may limit how you use the material learn more about cc licensing or use the license for your own material this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work make a donation this page is available in the following languages castellano castellano españa català dansk deutsch english esperanto français galego hrvatski indonesia italiano latviski lietuvių melayu nederlands norsk polski português português br română slovenščina suomeksi svenska türkçe íslenska česky ελληνικά беларуская русский українська العربية پارسی     한국어 this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work when you share everyone wins contribute today to creative commons     disclaimer this deed highlights only some of the key features and terms of the actual license it is not a license and has no legal value you should carefully review all of the terms and conditions of the actual license before using the licensed material creative commons is not a law firm and does not provide legal services distributing displaying or linking to this deed or the license that it summarizes does not create a lawyerclient or any other relationship what does attribute this work mean the page you came from contained embedded licensing metadata including how the creator wishes to be attributed for reuse you can use the html here to cite the work doing so will also include metadata on your page so that others can find the original work as well the applicable mediation rules will be designated in the copyright notice published with the work or if none then in the request for mediation unless otherwise designated in a copyright notice attached to the work the uncitral arbitration rules apply to any arbitration more info if supplied you must provide the name of the creator and attribution parties a copyright notice a license notice a disclaimer notice and a link to the material cc licenses prior to version  also require you to provide the title of the material if supplied and may have other slight differences more info in  you must indicate if you modified the material and retain an indication of previous modifications in  and earlier license versions the indication of changes is only required if you create a derivative marking guide more info you may also use a license listed as compatible at httpscreativecommonsorgcompatiblelicenses more info a commercial use is one primarily intended for commercial advantage or monetary compensation more info merely changing the format never creates a derivative more info the license prohibits application of effective technological measures defined with reference to article  of the wipo copyright treaty more info the rights of users under exceptions and limitations such as fair use and fair dealing are not affected by the cc licenses more info you may need to get additional permissions before using the material as you intend more info home  catalent sign up now to stay current with the latest news and insights subscribe now development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp events about us contact us visit another site global our regional sites chinakorea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish developmentdeliverysupplyofferings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all articlewhitepaper brochure case study ebook offering info poster presentation webinars news amp eventsabout uscontact us catalent is the  partner in helping pharmaceutical biotech and consumer health innovators develop deliver and supply superior products that improve people’s lives play video how can we work together drug development delivery  supply biologics consumer health explore the range of delivery options for your molecule this web tool enables drug development professionals to solve one of the most challenging aspects in drug development determining the optimal finished dose suited to your specific product requirements target indication and molecule properties learn more how can we work together drug development delivery  supply biologics consumer health why catalent unrivaled experience expertise and a track recordof market successes on a global scalelearn more about us how can we work together drug development delivery  supply biologics consumer health latest news pfizer partners with catalent on the new advil® liquigels® minis launch catalent launches expanded optiform® solution suite a complete early development offering catalent pharma solutions has launched the expanded optiform® solution suite platform extending the scope of the service to efficiently guide a molecule’s progress from candidate selection to phase i clinic supplies using integrated capabilities and a datadriven process for faster early phase development  learn more our solutions improve your treatments at every stage catalent shares the passion to unlock the potential of your product offering comprehensive solutions and superior technologies for oral biologic sterile and inhaled dose forms at every phase  from preclinical formulation through commercial supply clinical supply services need to accelerate your clinical trial partner with a leading global provider of integrated clinical trial supply solutions from clinical manufacturing packaging and comparator procurement to global logistics we can help optiform® pro web tool what dose form would work the best for your challenging molecule our tool can provide multiple sciencebased options try it now our facilities around the world enable us to tailor a solution to fit your needs see all of our locationsor visit our local language siteschinajapansouth america spanishportuguese news events twitter catalent applied drug delivery institute appoints jim spavins to advisory board jul   catalent applied drug delivery institute partners with rutgers university jul   catalent launches new optiform® solution suite jul   aug  expofybi  buenos aires argentina sep  vitafoods asia singapore asia sep  controlled  modified drug release philadelphia pa view all view all follow us catalentpharma resource library subscribe investors careers contact us site map follow us share us copyright  catalent inc  all right reserved privacy terms modern slavery statement catalent  wikipedia catalent from wikipedia the free encyclopedia jump to navigation search this article contains content that is written like an advertisement please help improve it by removing promotional content and inappropriate external links and by adding encyclopedic content written from a neutral point of view july  learn how and when to remove this template message catalent inc type public company traded as nyse ctlt sp  component industry pharmaceutical biotechnology predecessor cardinal health pts founded  headquarters somerset new jersey usa number of locations  key people john chiminski president ceo matthew walsh executive vice president cfo services drug preformulation formulation analytical testing clinical and commercial manufacturing clinical packaging and supply chain solutions regulatory consulting revenue us billion  operating income us  million  net income us  million  number of employees   website wwwcatalentcom catalent inc catalent pharma solutions is a global provider of drug delivery technology and development solutions for drugs biologics and consumer health products headquartered in somerset new jersey catalent operates  locations across five continents producing more than  billion doses annually for nearly  customer products originally created through a series of acquisitions by cardinal health inc catalent became independent in  catalent promotes its ability to increase customers speed to market and its participation in nearly half of new drug entities approved by the food and drug administration in the last decade the company currently holds approximately  patents and patent applications and continues to expand its offerings through investments in emerging technologies in its fiscal year  ending june  catalent’s customers included  of the top  branded drug marketers  of the top  generics marketers  of the top  biologics marketers and  of the top  consumer health marketers globallycitation needed on july   catalent became a public company and is listed on the new york stock exchange nyse ctlt contents  history  before   formation of catalent in   after  and initial public offering  corporate governance  senior management  drug delivery technologies  centers of excellence  references historyedit before edit in  cardinal health acquired pci headquarters philadelphia pennsylvania pci packaging coordinators inc is a pharmaceutical contract packing service for commercial and clinical packaging in  cardinal health acquired rp scherer corporation headquarters troy michigan robert pauli scherer founded the rp scherer corporation to commercialize his innovation of softgel encapsulation using the rotary die production process in  cardinal health acquired automatic liquid packaging inc headquarters woodstock ill whose blowfillseal technology allowed cardinal to enter the sterile product market cardinal health also acquired international processing corporation headquarters winchester kentucky for its advanced controlled drug release and coating manufacturing expertise in  cardinal health acquired magellan laboratories inc a company that specialized in product development expertise in  cardinal health acquired gala biotech headquarters middleton wisconsin gala biotech had established technologies surrounding gene insertion and the production of pharmaceutical proteins which became gpex® technology in the same year cardinal health also acquired intercare group plc broadening its global capabilities in europe in  cardinal health further expanded its reach in biotechnology and pharmaceutical markets through multiple other acquisitions formation of catalent in edit in  the pharmaceutical technologies and services segment of cardinal health was purchased by blackstone group and rebranded as catalent pharma solutions after  and initial public offeringedit in  the company acquired the molecular optimization platform optiform® from glaxosmithkline in  catalent acquired aptuit a clinical supply solutions company as part of the deal catalent gained three sites in the united states two sites in the united kingdom and one in singapore catalent also acquired all remaining shares for the rp scherer site in eberbach germany in  catalent pharmaceutical solutions continued the global expansion of its softgel capabilities through a joint venture with zhejiang jaing yuan tang biotechnology co a chinabased company and relthy laboratories in brazil also in  catalent created a new business unit advanced delivery technologies which focuses on innovative and proven drug delivery technologies optimizing the company’s multiple technologies crossplatform rd solutions and global commercial manufacturing network this is the current structure of catalent’s business which includes softgel technologies advanced delivery technologies and development  clinical services business units catalent announced its initial public offering on july   after raising more than  million catalent became a publicly traded company on the new york stock exchange nyse the company priced its  million shares of common stock at  apiece with a market capitalization of  billion the shares began trading on the nyse on july   under the ticker symbol ctlt and the offering closed on august   the proceeds of the offering went to the redemption of more than  million of catalent’s outstanding debt “this will allow the company to significantly reduce its interest expense enable future potential internal and external growth strategies and to continue our growthbiased investments into new technologies capabilities global development and manufacturing facilities and capacity” a company statement reported in september  the company acquired the contract drug development and clinical manufacturing company which specializes in early stage development and spray drying pharmatek laboratories in november  the company agreed to acquire canadian based accucaps industries both the strathroy on and windsor on locations will become the th and th softgel technology facilities under the catalent name corporate governanceedit senior managementedit position name since president  chief executive officer and director john r chiminski march  executive vice president and chief financial officer matthew walsh december  president development and clinical services wetteny joseph august  president softgel technologies aris gennadios september  president advanced delivery technologies barry littlejohns july  senior vice president chief information officer michael del priore december  senior vice president global sales  marketing william downie june  senior vice president quality product development and regulatory affairs sharon johnson august  senior vice president global operations stephen leonard june  senior vice president human resources lance miyamoto march  senior vice president general counsel steven fasman october  drug delivery technologiesedit catalents brand currently owns and operates the following drug delivery technologies predevelopment technologies optiform technology catalent micron technologies oral drug delivery technologies rp scherer softgel technology optigel technology optigel lock technology optigel micro technology optigel mini technology zydis technology osdrc optidose drug delivery technology optimelt technology optipact technology sterile technologies advasept technology biologics smartag technology gpex technology centers of excellenceedit catalent has designated the following locations as a center of excellence with the following specializations swindon united kingdom – zydis technology somerset new jersey – osdrc optidose drug delivery technology philadelphia pennsylvania – clinical supply services st petersburg florida – rp scherer softgel technology woodstock illinois – blowfillseal bfs technology winchester kentucky – advanced oral delivery technologies madison wisconsin – gpex technology research triangle park north carolina – inhalation referencesedit  a b c d e f g h i j k l m n the united states securities and exchange commission  form k washington dc catalent pharma solutions catalent pharma solutions retrieved    a b c catalent pharma solutions  catalent reports fourth quarter and fiscal year  results catalent pharma solutions retrieved    our locations catalentcom catalent inc retrieved  nov    a b c d e f cardinal healths timeline  cardinalhealthcom cardinalhealthcom retrieved  april    pci leads the market in healthcare packaging solutions pci services retrieved  april    a b catalent completes acquisition of r p scherer eberbach manufacturing chemist  march  retrieved  april    a b kuehn steven  october  container innovations prairie home pharmaceutical manufacturing retrieved  april    rp scherer to gain new drugdelivery business with acquisition of international processing corporation cmo cro pr newswire  december  retrieved  april    cardinal health to enhance drug development services with acquisition of gala biotech cardinal health inc pr newswire  oct  retrieved  april    cardinal health completes sale of pharmaceutical technologies and services segment to the blackstone group dublin ohio blackstone group  april    ohnesorge lauren k  january  catalent cements local footprint triangle business journal retrieved  april    catalent completes aptuit deal biopharmareportercom  february  retrieved  april    stanton dan  october  catalents brazilian acquisition supports global softgel strategy inpharmatechnologistcom retrieved  april    catalent creates new advanced delivery technologies business unit catalent inc pr web  july  retrieved  april    a b catalent issues initial public offering  pharmtechcom pharmaceutical technology sourcing and management  august  retrieved  april    catalent issues initial public offering catalentcom catalent inc retrieved  april    httpwwwgenengnewscomgennewshighlightscatalenttoacquirepharmatek  httpwwwcatalentcomindexphpnewseventsnewscatalentacquiresaccucapstoexpandsoftgeldevelopmentandmanufacturingcapabilitiesandcapacity  our leadership catalent catalent inc retrieved  nov    a b c catalent announces new optimized drug delivery technologies at cphl worldwideicse redorbit  october  retrieved  april    new optipact™ technology introduced by catalent catalent inc pr web  september  retrieved  april    a b catalent expands its technology offerings in biologics acquires redwood bioscience inc and the smartag™ technology platform catalent pharma solutions marketwatch  october  retrieved  april   retrieved from httpsenwikipediaorgwindexphptitlecatalentoldid categories companies based in somerset county new jerseypharmaceutical companies established in companies listed on the new york stock exchangepharmaceutical companies based in new jerseyhidden categories articles with a promotional tone from july all articles with a promotional toneuse dmy dates from april all articles with unsourced statementsarticles with unsourced statements from july  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  february  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view catalent pharma catalentpharma  twitter skip to content home home home current page moments moments moments current page search query search twitter saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  language english bahasa indonesia bahasa melayu català čeština dansk deutsch english uk español filipino français hrvatski italiano magyar nederlands norsk polski português română slovenčina suomi svenska tiếng việt türkçe ελληνικά български език русский српски українська мова עִבְרִית العربية فارسی मराठी हिन्दी বাংলা ગુજરાતી தமிழ் ಕನ್ನಡ ภาษาไทย 한국어  简体 繁體 have an account log in have an account remember me · forgot password new to twitter sign up catalent pharma catalentpharma tweets tweets current page  following following  followers followers k likes likes  lists lists    more likes lists unmute catalentpharma mute catalentpharma follow following unfollow blocked unblock pending cancel catalent pharma catalentpharma from drug and biologic development services to delivery technologies to supply solutions catalent more products better treatments reliably supplied™ somerset nj catalentcom joined march   photos and videos photos and videos tweets tweets tweets current page tweets  replies media you blocked catalentpharma are you sure you want to view these tweets viewing tweets wont unblock catalentpharma yes view profile close catalent pharma followed catalent pharma‏ catalentpharma h hours ago more copy link to tweet embed tweet news update  catalent applied drug delivery institute appoints jim spavins to advisory board  httpowlyannxdxmyy   replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet catalent’s bryan knox will be presenting as the formulation expert in the upcoming biocomca event on cmc needs  httpowlyulsdwer   replies  retweets  like reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet speaking session today at ddpconf by cornell stamoran catalent at pm est  register for free httpowlyuvajdocnl pictwittercomqypozyodl  reply  retweets  like reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet new video on a fast flexible and factbased path for your molecule to progress from latestage discovery to phase ihttpowlysadsxpu   replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo catalent pharma retweeted manufacturingchemist‏ manchempharma jul  more copy link to tweet embed tweet optiform solution suite launched catalentpharma innovatehealth  httpbitlyuqcpes pictwittercomqbalmtmzx  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma retweeted pharma integrates‏ pharmaintegrate jul  more copy link to tweet embed tweet catalent partners with rutgersu to better understand paediatric drug formulation and delivery httpowlyrwivdroy  catalentpharma  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet upcoming speaking session at ddpconf by cornell stamoran catalent tuesday  at pm  register for free httpowlyuvajdocnl pictwittercomwzpqjbzi  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet get latest expert opinions on patientcentricity  directtopatient trials in clinicaltrial design download ebook httpowlyjefpdhkhb pictwittercomxamhdgdi  replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet download article  latest on technology management approach to ensure a reliable supply of products to market  httpowlyubbjkav pictwittercomtuseukhh  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet catalent networking reception at crsboston announcing new optiform® solution suite  httpowlyvwyydhf  crssciencepictwittercomaubdq  replies  retweet  like reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet optiform® solution suite provides an efficient  seamless path from latestage discovery to phase i clinicaltrials httpowlyiapsdgexp   replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo catalent pharma retweeted catalent institute‏ drugdeliveryins jul  more copy link to tweet embed tweet randy mrsny discussed simplifying the process of drug development during catalentpharma sponsored industry roundtable at crsscience pictwittercomsaueznif  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet now at crsboston  catalent sponsored industry roundtable featuring cornell stamoran catalent httpowlyvwyydhf  crssciencepictwittercomhvaiemdq  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet designing nutritional supplements download article on all natural technology compatible with multiple excipients  httpowlyksxmavyl pictwittercomgoalool  replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet speaking now at catalentconnect during crsboston is gil roth president pharma  biopharma outsourcing association httpowlyvwyydhf pictwittercomjmsopkxbt  reply  retweet  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet cornell stamoran at catalentconnect meet cornell at p today during the crsboston industry roundtable  httpowlyvwyydhf pictwittercomsgvjonf  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet new optiform® solution suite for an efficient  seamless path from latestage discovery to phase i clinical trials  httpowlyatytdgdc   replies  retweet  likes reply retweet  retweeted  like liked thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet catalentconnect meeting at crsboston jim spavins presenting early development making the right decisions up front httpowlyvwyydhf pictwittercomtwmetywig  replies  retweet  likes reply retweet  retweeted  like liked thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet the expo hall at crsboston is open visit catalent at booth  to speak with our team of experts httpowlyvwyydhf  crssciencepictwittercomjvdodqpik  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo catalent pharma‏ catalentpharma jul  more copy link to tweet embed tweet final speaker at crsboston premeeting workshop is dr patrick crowley thank you to all who attended httpowlyfqrrcxhzm  crssciencepictwittercomngaehqdy  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo catalentpharma hasnt tweeted yet back to top ↑ loading seems to be taking a while twitter may be over capacity or experiencing a momentary hiccup try again or visit twitter status for more information new to twitter sign up now to get your own personalized timeline sign up you may also like · refresh false   twitter about help center terms privacy policy cookies ads info close choose a trend location dismiss close previous next close go to a persons profile saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  close promote this tweet close block cancel block add a location to your tweets when you tweet with a location twitter stores that location you can switch location onoff before each tweet and always have the option to delete your location history learn more turn location on not now close share location results from send close your lists close create a new list list name description under  characters optional privacy public · anyone can follow this list private · only you can access this list save list close close copy link to tweet heres the url for this tweet copy it to easily share with friends close embed this tweet embed this video add this tweet to your website by copying the code below learn more add this video to your website by copying the code below learn more hmm there was a problem reaching the server try again include parent tweet include media by embedding twitter content in your website or app you are agreeing to the twitter developer agreement and developer policy preview close why youre seeing this ad close log in to twitter remember me · forgot password dont have an account sign up » close sign up for twitter not on twitter sign up tune into the things you care about and get updates as they happen sign up have an account log in » close twoway sending and receiving short codes country code for customers of united states  any canada  any united kingdom  vodafone orange  o brazil  nextel tim haiti  digicel voila ireland  vodafone o india  bharti airtel videocon reliance indonesia  axis  telkomsel indosat xl axiata italy  wind  vodafone » see sms short codes for other countries close confirmation close   close skip all welcome home this timeline is where you’ll spend most of your time getting instant updates about what matters to you tweets not working for you hover over the profile pic and click the following button to unfollow any account say a lot with a little when you see a tweet you love tap the heart — it lets the person who wrote it know you shared the love spread the word the fastest way to share someone else’s tweet with your followers is with a retweet tap the icon to send it instantly join the conversation add your thoughts about any tweet with a reply find a topic you’re passionate about and jump right in learn the latest get instant insight into what people are talking about now get more of what you love follow more accounts to get instant updates about topics you care about find whats happening see the latest conversations about any topic instantly never miss a moment catch up instantly on the best stories happening as they unfold back next next tweet from user catalent  wikipedia catalent from wikipedia the free encyclopedia jump to navigation search this article contains content that is written like an advertisement please help improve it by removing promotional content and inappropriate external links and by adding encyclopedic content written from a neutral point of view july  learn how and when to remove this template message catalent inc type public company traded as nyse ctlt sp  component industry pharmaceutical biotechnology predecessor cardinal health pts founded  headquarters somerset new jersey usa number of locations  key people john chiminski president ceo matthew walsh executive vice president cfo services drug preformulation formulation analytical testing clinical and commercial manufacturing clinical packaging and supply chain solutions regulatory consulting revenue us billion  operating income us  million  net income us  million  number of employees   website wwwcatalentcom catalent inc catalent pharma solutions is a global provider of drug delivery technology and development solutions for drugs biologics and consumer health products headquartered in somerset new jersey catalent operates  locations across five continents producing more than  billion doses annually for nearly  customer products originally created through a series of acquisitions by cardinal health inc catalent became independent in  catalent promotes its ability to increase customers speed to market and its participation in nearly half of new drug entities approved by the food and drug administration in the last decade the company currently holds approximately  patents and patent applications and continues to expand its offerings through investments in emerging technologies in its fiscal year  ending june  catalent’s customers included  of the top  branded drug marketers  of the top  generics marketers  of the top  biologics marketers and  of the top  consumer health marketers globallycitation needed on july   catalent became a public company and is listed on the new york stock exchange nyse ctlt contents  history  before   formation of catalent in   after  and initial public offering  corporate governance  senior management  drug delivery technologies  centers of excellence  references historyedit before edit in  cardinal health acquired pci headquarters philadelphia pennsylvania pci packaging coordinators inc is a pharmaceutical contract packing service for commercial and clinical packaging in  cardinal health acquired rp scherer corporation headquarters troy michigan robert pauli scherer founded the rp scherer corporation to commercialize his innovation of softgel encapsulation using the rotary die production process in  cardinal health acquired automatic liquid packaging inc headquarters woodstock ill whose blowfillseal technology allowed cardinal to enter the sterile product market cardinal health also acquired international processing corporation headquarters winchester kentucky for its advanced controlled drug release and coating manufacturing expertise in  cardinal health acquired magellan laboratories inc a company that specialized in product development expertise in  cardinal health acquired gala biotech headquarters middleton wisconsin gala biotech had established technologies surrounding gene insertion and the production of pharmaceutical proteins which became gpex® technology in the same year cardinal health also acquired intercare group plc broadening its global capabilities in europe in  cardinal health further expanded its reach in biotechnology and pharmaceutical markets through multiple other acquisitions formation of catalent in edit in  the pharmaceutical technologies and services segment of cardinal health was purchased by blackstone group and rebranded as catalent pharma solutions after  and initial public offeringedit in  the company acquired the molecular optimization platform optiform® from glaxosmithkline in  catalent acquired aptuit a clinical supply solutions company as part of the deal catalent gained three sites in the united states two sites in the united kingdom and one in singapore catalent also acquired all remaining shares for the rp scherer site in eberbach germany in  catalent pharmaceutical solutions continued the global expansion of its softgel capabilities through a joint venture with zhejiang jaing yuan tang biotechnology co a chinabased company and relthy laboratories in brazil also in  catalent created a new business unit advanced delivery technologies which focuses on innovative and proven drug delivery technologies optimizing the company’s multiple technologies crossplatform rd solutions and global commercial manufacturing network this is the current structure of catalent’s business which includes softgel technologies advanced delivery technologies and development  clinical services business units catalent announced its initial public offering on july   after raising more than  million catalent became a publicly traded company on the new york stock exchange nyse the company priced its  million shares of common stock at  apiece with a market capitalization of  billion the shares began trading on the nyse on july   under the ticker symbol ctlt and the offering closed on august   the proceeds of the offering went to the redemption of more than  million of catalent’s outstanding debt “this will allow the company to significantly reduce its interest expense enable future potential internal and external growth strategies and to continue our growthbiased investments into new technologies capabilities global development and manufacturing facilities and capacity” a company statement reported in september  the company acquired the contract drug development and clinical manufacturing company which specializes in early stage development and spray drying pharmatek laboratories in november  the company agreed to acquire canadian based accucaps industries both the strathroy on and windsor on locations will become the th and th softgel technology facilities under the catalent name corporate governanceedit senior managementedit position name since president  chief executive officer and director john r chiminski march  executive vice president and chief financial officer matthew walsh december  president development and clinical services wetteny joseph august  president softgel technologies aris gennadios september  president advanced delivery technologies barry littlejohns july  senior vice president chief information officer michael del priore december  senior vice president global sales  marketing william downie june  senior vice president quality product development and regulatory affairs sharon johnson august  senior vice president global operations stephen leonard june  senior vice president human resources lance miyamoto march  senior vice president general counsel steven fasman october  drug delivery technologiesedit catalents brand currently owns and operates the following drug delivery technologies predevelopment technologies optiform technology catalent micron technologies oral drug delivery technologies rp scherer softgel technology optigel technology optigel lock technology optigel micro technology optigel mini technology zydis technology osdrc optidose drug delivery technology optimelt technology optipact technology sterile technologies advasept technology biologics smartag technology gpex technology centers of excellenceedit catalent has designated the following locations as a center of excellence with the following specializations swindon united kingdom – zydis technology somerset new jersey – osdrc optidose drug delivery technology philadelphia pennsylvania – clinical supply services st petersburg florida – rp scherer softgel technology woodstock illinois – blowfillseal bfs technology winchester kentucky – advanced oral delivery technologies madison wisconsin – gpex technology research triangle park north carolina – inhalation referencesedit  a b c d e f g h i j k l m n the united states securities and exchange commission  form k washington dc catalent pharma solutions catalent pharma solutions retrieved    a b c catalent pharma solutions  catalent reports fourth quarter and fiscal year  results catalent pharma solutions retrieved    our locations catalentcom catalent inc retrieved  nov    a b c d e f cardinal healths timeline  cardinalhealthcom cardinalhealthcom retrieved  april    pci leads the market in healthcare packaging solutions pci services retrieved  april    a b catalent completes acquisition of r p scherer eberbach manufacturing chemist  march  retrieved  april    a b kuehn steven  october  container innovations prairie home pharmaceutical manufacturing retrieved  april    rp scherer to gain new drugdelivery business with acquisition of international processing corporation cmo cro pr newswire  december  retrieved  april    cardinal health to enhance drug development services with acquisition of gala biotech cardinal health inc pr newswire  oct  retrieved  april    cardinal health completes sale of pharmaceutical technologies and services segment to the blackstone group dublin ohio blackstone group  april    ohnesorge lauren k  january  catalent cements local footprint triangle business journal retrieved  april    catalent completes aptuit deal biopharmareportercom  february  retrieved  april    stanton dan  october  catalents brazilian acquisition supports global softgel strategy inpharmatechnologistcom retrieved  april    catalent creates new advanced delivery technologies business unit catalent inc pr web  july  retrieved  april    a b catalent issues initial public offering  pharmtechcom pharmaceutical technology sourcing and management  august  retrieved  april    catalent issues initial public offering catalentcom catalent inc retrieved  april    httpwwwgenengnewscomgennewshighlightscatalenttoacquirepharmatek  httpwwwcatalentcomindexphpnewseventsnewscatalentacquiresaccucapstoexpandsoftgeldevelopmentandmanufacturingcapabilitiesandcapacity  our leadership catalent catalent inc retrieved  nov    a b c catalent announces new optimized drug delivery technologies at cphl worldwideicse redorbit  october  retrieved  april    new optipact™ technology introduced by catalent catalent inc pr web  september  retrieved  april    a b catalent expands its technology offerings in biologics acquires redwood bioscience inc and the smartag™ technology platform catalent pharma solutions marketwatch  october  retrieved  april   retrieved from httpsenwikipediaorgwindexphptitlecatalentoldid categories companies based in somerset county new jerseypharmaceutical companies established in companies listed on the new york stock exchangepharmaceutical companies based in new jerseyhidden categories articles with a promotional tone from july all articles with a promotional toneuse dmy dates from april all articles with unsourced statementsarticles with unsourced statements from july  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages français edit links this page was last edited on  february  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view